Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	nucleoside-triphosphatase regulator activity	STARD13 RABEP2 RASGRP4 MYCBP2 ARHGAP36 EPS8L1 CAVIN4 RAPGEF3 SGSM3 SIPA1L2 RGL2 TBCD GARNL3 ARHGEF5 SH2D3C RGS14 TIAM1 DENND2C DOCK7 MTSS2 RAPGEFL1	6.42e-06	507	271	21	GO:0060589
GeneOntologyMolecularFunction	GTPase regulator activity	STARD13 RABEP2 RASGRP4 MYCBP2 ARHGAP36 EPS8L1 CAVIN4 RAPGEF3 SGSM3 SIPA1L2 RGL2 TBCD GARNL3 ARHGEF5 SH2D3C RGS14 TIAM1 DENND2C DOCK7 MTSS2 RAPGEFL1	6.42e-06	507	271	21	GO:0030695
GeneOntologyMolecularFunction	cytoskeletal motor activity	STARD9 KIFC3 MYO18B DNAH5 KIF11 KIF23 MYH7B DNAI1	2.10e-04	118	271	8	GO:0003774
GeneOntologyMolecularFunction	cytoskeletal protein binding	SPTBN1 EPS8L1 PTK2 LRP8 PTPN3 STARD9 AFDN MICAL3 TTLL1 KIFC3 PLEC MYO18B USH2A MAP4K4 KLC3 TBCD KIF11 MICAL1 SHROOM3 KIF23 ANK1 MYH7B KLC4 CCDC61 RGS14 TIAM1 INF2 CROCC MTSS2 KLHL17	2.19e-04	1099	271	30	GO:0008092
GeneOntologyMolecularFunction	calcium ion transmembrane transporter activity	TRPM4 TRPC4 PKD1L1 CACNA1G TRPM1 GRIN3B SLC30A10 ATP13A4 CACNB1	2.26e-04	151	271	9	GO:0015085
GeneOntologyMolecularFunction	ATP-dependent activity	ABCC3 MCM7 SRCAP DDX5 MDN1 ATP8A1 STARD9 KIFC3 DNAH5 DDX11L8 KIF11 ATP13A4 KIF23 LONP2 MYH7B SAE1 ABCB10 MCM9 HELZ2 ATP6V0A2	2.92e-04	614	271	20	GO:0140657
GeneOntologyMolecularFunction	guanyl-nucleotide exchange factor activity	RASGRP4 MYCBP2 EPS8L1 RAPGEF3 RGL2 ARHGEF5 SH2D3C TIAM1 DENND2C DOCK7 RAPGEFL1	3.33e-04	231	271	11	GO:0005085
GeneOntologyBiologicalProcess	homophilic cell adhesion via plasma membrane adhesion molecules	DCHS2 CDH26 PCDH12 FAT2 HMCN2 PCDH19 PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA4 PCDHB7 PCDHGB4 PCDH8	1.87e-08	187	263	15	GO:0007156
GeneOntologyBiologicalProcess	cell-cell adhesion via plasma-membrane adhesion molecules	DCHS2 CDH26 SCARF2 PCDH12 FAT2 LRFN4 HMCN2 NRXN1 PCDH19 PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA4 PCDHB7 PCDHGB4 MDGA1 PCDH8	2.29e-08	313	263	19	GO:0098742
GeneOntologyBiologicalProcess	cell-cell adhesion	CBLL1 DCHS2 CDH26 SCARF2 PKD1L1 PCDH12 NPHP4 PTK2 BMP5 FAT2 LRFN4 HMCN2 NRXN1 NRXN2 PCDH19 AFDN LOXL3 KIFC3 PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA4 MINK1 ICAM3 PCDHB7 HAVCR2 PCDHGB4 LRP5 MDGA1 PCDH8	7.76e-06	1077	263	32	GO:0098609
GeneOntologyBiologicalProcess	presynaptic signal transduction	SIPA1L2 PCLO CTBP1	8.12e-06	4	263	3	GO:0098928
GeneOntologyBiologicalProcess	cell junction organization	CDH26 MYCBP2 NPHP4 PTK2 LRP8 LRFN4 HMCN2 NRXN1 NRXN2 AFDN KIFC3 PLEC ADGRF1 MAP4K4 TBCD CACNB1 LRFN1 PCLO LAMA5 TIAM1 RIMS4 EIF4G1 DOCK7 LINGO4 LRP5 PEAK1 MDGA1 PCDH8	5.33e-05	974	263	28	GO:0034330
GeneOntologyCellularComponent	anchoring junction	DCHS2 KLHL24 GAK CDH26 SCARF2 RPS5 TRPC4 ZNF185 EVPL PCDH12 NPHP4 PTK2 FAT2 NRXN1 AFDN SGSM3 KIFC3 PLEC MAP4K4 TBCD HSPG2 SHROOM3 KIF23 ARHGEF5 PARD3B HAVCR2 TIAM1 SH3PXD2A CSPG4 DOCK7 PEAK1 ATP6V0A2	1.33e-06	976	270	32	GO:0070161
GeneOntologyCellularComponent	cell cortex	TRPC4 SPTBN1 ARFIP2 PTK2 HMCN2 RAPGEF3 KHDC3L MICAL3 SHROOM3 ANK1 PCLO PARD3B EXOC8 RIMS4 CTBP1 CTBP2 MTSS2	7.34e-06	371	270	17	GO:0005938
GeneOntologyCellularComponent	presynaptic active zone	NRXN1 NRXN2 AFDN GRIN3B LRFN1 PCLO RIMS4 CTBP1 CTBP2	9.29e-05	141	270	9	GO:0048786
GeneOntologyCellularComponent	presynaptic active zone cytoplasmic component	PCLO RIMS4 CTBP1 CTBP2	1.99e-04	23	270	4	GO:0098831
GeneOntologyCellularComponent	cortical cytoskeleton	TRPC4 SPTBN1 RAPGEF3 SHROOM3 ANK1 PCLO RIMS4 MTSS2	2.77e-04	129	270	8	GO:0030863
GeneOntologyCellularComponent	kinesin complex	KIFC3 KLC3 KIF11 KIF23 KLC4	4.15e-04	49	270	5	GO:0005871
GeneOntologyCellularComponent	axon	KLHL24 MYCBP2 SPTBN1 ADAM11 LRP8 HMCN2 NRXN1 RAPGEF3 AFDN TRPM1 PLEC USH2A ALK MICAL1 ANK1 PCLO MINK1 SH2D3C EXOC8 RNF6 TIAM1 DOCK7 WDFY3 MDGA1	5.78e-04	891	270	24	GO:0030424
GeneOntologyCellularComponent	ribbon synapse	NPHP4 RAPGEF3 PCLO CTBP2	7.36e-04	32	270	4	GO:0097470
Domain	Cadherin_CS	DCHS2 CDH26 PCDH12 FAT2 PCDH19 PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA4 PCDHB7 PCDHGB4 PCDH8	3.76e-10	109	261	14	IPR020894
Domain	CADHERIN_1	DCHS2 CDH26 PCDH12 FAT2 PCDH19 PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA4 PCDHB7 PCDHGB4 PCDH8	6.12e-10	113	261	14	PS00232
Domain	Cadherin	DCHS2 CDH26 PCDH12 FAT2 PCDH19 PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA4 PCDHB7 PCDHGB4 PCDH8	6.12e-10	113	261	14	PF00028
Domain	CADHERIN_2	DCHS2 CDH26 PCDH12 FAT2 PCDH19 PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA4 PCDHB7 PCDHGB4 PCDH8	6.89e-10	114	261	14	PS50268
Domain	-	DCHS2 CDH26 PCDH12 FAT2 PCDH19 PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA4 PCDHB7 PCDHGB4 PCDH8	6.89e-10	114	261	14	2.60.40.60
Domain	CA	DCHS2 CDH26 PCDH12 FAT2 PCDH19 PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA4 PCDHB7 PCDHGB4 PCDH8	7.75e-10	115	261	14	SM00112
Domain	Cadherin-like	DCHS2 CDH26 PCDH12 FAT2 PCDH19 PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA4 PCDHB7 PCDHGB4 PCDH8	8.70e-10	116	261	14	IPR015919
Domain	Cadherin	DCHS2 CDH26 PCDH12 FAT2 PCDH19 PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA4 PCDHB7 PCDHGB4 PCDH8	1.09e-09	118	261	14	IPR002126
Domain	Cadherin_2	PCDH12 PCDH19 PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA4 PCDHB7 PCDHGB4 PCDH8	1.48e-09	65	261	11	PF08266
Domain	Cadherin_N	PCDH12 PCDH19 PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA4 PCDHB7 PCDHGB4 PCDH8	1.48e-09	65	261	11	IPR013164
Domain	LAM_G_DOMAIN	FAT2 NRXN1 NRXN2 USH2A HSPG2 LAMA2 LAMA5 CSPG4	4.45e-08	38	261	8	PS50025
Domain	Laminin_G_2	FAT2 NRXN1 NRXN2 USH2A HSPG2 LAMA2 LAMA5 CSPG4	6.82e-08	40	261	8	PF02210
Domain	Cadherin_C	PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA4 PCDHB7 PCDHGB4	1.02e-07	42	261	8	IPR032455
Domain	Cadherin_C_2	PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA4 PCDHB7 PCDHGB4	1.02e-07	42	261	8	PF16492
Domain	LamG	FAT2 NRXN1 NRXN2 USH2A HSPG2 LAMA2 LAMA5 CSPG4	1.50e-07	44	261	8	SM00282
Domain	Cadherin_tail	PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA4 PCDHGB4	6.91e-07	37	261	7	PF15974
Domain	Cadherin_CBD	PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA4 PCDHGB4	6.91e-07	37	261	7	IPR031904
Domain	-	FAT2 NRXN1 NRXN2 USH2A HSPG2 LAMA2 LAMA5 CSPG4 WDFY3 LRBA	8.52e-07	95	261	10	2.60.120.200
Domain	Laminin_G	FAT2 NRXN1 NRXN2 USH2A HSPG2 LAMA2 LAMA5 CSPG4	1.37e-06	58	261	8	IPR001791
Domain	ConA-like_dom	FAT2 NRXN1 NRXN2 USH2A ALK HSPG2 LAMA2 LAMA5 MAMDC4 CSPG4 WDFY3 LRBA MDGA1	1.33e-05	219	261	13	IPR013320
Domain	RASGEF	RASGRP4 RAPGEF3 RGL2 SH2D3C RAPGEFL1	2.65e-05	26	261	5	PS00720
Domain	CNH	TNIK MAP4K4 GARNL3 MINK1	3.34e-05	14	261	4	SM00036
Domain	CNH	TNIK MAP4K4 GARNL3 MINK1	4.51e-05	15	261	4	PF00780
Domain	CNH	TNIK MAP4K4 GARNL3 MINK1	4.51e-05	15	261	4	PS50219
Domain	CNH_dom	TNIK MAP4K4 GARNL3 MINK1	4.51e-05	15	261	4	IPR001180
Domain	RASGEF_CAT	RASGRP4 RAPGEF3 RGL2 SH2D3C RAPGEFL1	4.63e-05	29	261	5	PS50009
Domain	Rab5-bind	RABEP2 KLC3 KLC4	5.23e-05	6	261	3	PF09311
Domain	Rabaptin_Rab5-bd_dom	RABEP2 KLC3 KLC4	5.23e-05	6	261	3	IPR015390
Domain	RasGEF	RASGRP4 RAPGEF3 RGL2 SH2D3C RAPGEFL1	5.49e-05	30	261	5	PF00617
Domain	-	RASGRP4 RAPGEF3 RGL2 SH2D3C RAPGEFL1	5.49e-05	30	261	5	1.10.840.10
Domain	RASGEF_cat_dom	RASGRP4 RAPGEF3 RGL2 SH2D3C RAPGEFL1	5.49e-05	30	261	5	IPR001895
Domain	RasGEF	RASGRP4 RAPGEF3 RGL2 SH2D3C RAPGEFL1	5.49e-05	30	261	5	SM00147
Domain	Ras_GEF_dom	RASGRP4 RAPGEF3 RGL2 SH2D3C RAPGEFL1	5.49e-05	30	261	5	IPR023578
Domain	EGF_1	SCARF2 ADAM11 LRP8 FAT2 HMCN2 NRXN1 NRXN2 USH2A HSPG2 HBEGF LAMA2 LAMA5 LRP5	6.51e-05	255	261	13	PS00022
Domain	EGF_Lam	SCARF2 USH2A HSPG2 LAMA2 LAMA5	1.18e-04	35	261	5	SM00180
Domain	Laminin_EGF	SCARF2 USH2A HSPG2 LAMA2 LAMA5	1.18e-04	35	261	5	PF00053
Domain	LAMININ_IVA	HSPG2 LAMA2 LAMA5	1.43e-04	8	261	3	PS51115
Domain	Laminin_B	HSPG2 LAMA2 LAMA5	1.43e-04	8	261	3	PF00052
Domain	LamB	HSPG2 LAMA2 LAMA5	1.43e-04	8	261	3	SM00281
Domain	Laminin_IV	HSPG2 LAMA2 LAMA5	1.43e-04	8	261	3	IPR000034
Domain	Laminin_EGF	SCARF2 USH2A HSPG2 LAMA2 LAMA5	1.77e-04	38	261	5	IPR002049
Domain	ARHGEF5_35	ARHGEF5 ARHGEF35	1.95e-04	2	261	2	PF15441
Domain	ARHGEF5/35_N	ARHGEF5 ARHGEF35	1.95e-04	2	261	2	IPR029212
Domain	EGF-like_dom	SCARF2 ADAM11 LRP8 FAT2 HMCN2 NRXN1 NRXN2 HSPG2 HBEGF LAMA2 LAMA5 LRP5	2.10e-04	249	261	12	IPR000742
Domain	EGF-like_CS	SCARF2 ADAM11 LRP8 FAT2 HMCN2 NRXN1 NRXN2 HSPG2 HBEGF LAMA2 LAMA5 LRP5	3.22e-04	261	261	12	IPR013032
Domain	EGF_2	SCARF2 ADAM11 LRP8 FAT2 HMCN2 NRXN1 NRXN2 HSPG2 HBEGF LAMA2 LAMA5 LRP5	3.70e-04	265	261	12	PS01186
Domain	Laminin_G_1	HSPG2 LAMA2 CSPG4	4.10e-04	11	261	3	PF00054
Domain	-	LRP8 ALK HSPG2 MAMDC4 LRP5	4.40e-04	46	261	5	4.10.400.10
Domain	EGF	SCARF2 ADAM11 LRP8 FAT2 NRXN1 NRXN2 HSPG2 HBEGF LAMA2 LAMA5 LRP5	4.89e-04	235	261	11	SM00181
Domain	LDLRA_1	LRP8 ALK HSPG2 MAMDC4 LRP5	5.38e-04	48	261	5	PS01209
Domain	HARE-HTH	ASXL1 ASXL3	5.78e-04	3	261	2	PF05066
Domain	ASXH	ASXL1 ASXL3	5.78e-04	3	261	2	PF13919
Domain	PHD_3	ASXL1 ASXL3	5.78e-04	3	261	2	PF13922
Domain	ASX-like_PHD	ASXL1 ASXL3	5.78e-04	3	261	2	IPR026905
Domain	ASXH	ASXL1 ASXL3	5.78e-04	3	261	2	IPR028020
Domain	ASX/ASX-like	ASXL1 ASXL3	5.78e-04	3	261	2	IPR024811
Domain	HB1/Asxl_HTH	ASXL1 ASXL3	5.78e-04	3	261	2	IPR007759
Domain	LDrepeatLR_classA_rpt	LRP8 ALK HSPG2 MAMDC4 LRP5	5.92e-04	49	261	5	IPR002172
Domain	LDLa	LRP8 ALK HSPG2 MAMDC4 LRP5	5.92e-04	49	261	5	SM00192
Domain	LDLRA_2	LRP8 ALK HSPG2 MAMDC4 LRP5	5.92e-04	49	261	5	PS50068
Domain	EGF_LAM_2	USH2A HSPG2 LAMA2 LAMA5	7.67e-04	30	261	4	PS50027
Domain	EGF_LAM_1	USH2A HSPG2 LAMA2 LAMA5	7.67e-04	30	261	4	PS01248
Domain	AAA	ABCC3 MCM7 MDN1 DNAH5 LONP2 ABCB10 MCM9 HELZ2	9.59e-04	144	261	8	SM00382
Domain	AAA+_ATPase	ABCC3 MCM7 MDN1 DNAH5 LONP2 ABCB10 MCM9 HELZ2	9.59e-04	144	261	8	IPR003593
Domain	2-Hacid_dh_C	CTBP1 CTBP2	1.15e-03	4	261	2	PF02826
Domain	ROC_dom	MFHAS1 LRRK1	1.15e-03	4	261	2	IPR020859
Domain	ROC	MFHAS1 LRRK1	1.15e-03	4	261	2	PS51424
Domain	KN_motif	KANK1 KANK3	1.15e-03	4	261	2	IPR021939
Domain	2-Hacid_dh	CTBP1 CTBP2	1.15e-03	4	261	2	PF00389
Domain	Kinesin_light	KLC3 KLC4	1.15e-03	4	261	2	IPR002151
Domain	D_2_HYDROXYACID_DH_1	CTBP1 CTBP2	1.15e-03	4	261	2	PS00065
Domain	D_2_HYDROXYACID_DH_2	CTBP1 CTBP2	1.15e-03	4	261	2	PS00670
Domain	D_2_HYDROXYACID_DH_3	CTBP1 CTBP2	1.15e-03	4	261	2	PS00671
Domain	D-isomer_2_OHA_DH_cat_dom	CTBP1 CTBP2	1.15e-03	4	261	2	IPR006139
Domain	D-isomer_DH_CS	CTBP1 CTBP2	1.15e-03	4	261	2	IPR029753
Domain	KN_motif	KANK1 KANK3	1.15e-03	4	261	2	PF12075
Domain	PDZ	PTPN3 AFDN SIPA1L2 SHROOM3 PCLO PARD3B HTRA3 TIAM1	1.30e-03	151	261	8	PS50106
Domain	MAM_1	ALK MAMDC4 MDGA1	1.32e-03	16	261	3	PS00740
Domain	Laminin_N	USH2A LAMA2 LAMA5	1.32e-03	16	261	3	IPR008211
Domain	LamNT	USH2A LAMA2 LAMA5	1.32e-03	16	261	3	SM00136
Domain	LAMININ_NTER	USH2A LAMA2 LAMA5	1.32e-03	16	261	3	PS51117
Domain	Laminin_N	USH2A LAMA2 LAMA5	1.32e-03	16	261	3	PF00055
Domain	PDZ	PTPN3 AFDN SIPA1L2 SHROOM3 PCLO PARD3B HTRA3 TIAM1	1.36e-03	152	261	8	IPR001478
Domain	EGF_3	SCARF2 ADAM11 LRP8 FAT2 HMCN2 NRXN1 NRXN2 HSPG2 HBEGF LRP5	1.79e-03	235	261	10	PS50026
Domain	MAM	ALK MAMDC4 MDGA1	1.88e-03	18	261	3	PF00629
Domain	MAM_dom	ALK MAMDC4 MDGA1	1.88e-03	18	261	3	IPR000998
Domain	MAM_2	ALK MAMDC4 MDGA1	1.88e-03	18	261	3	PS50060
Domain	Laminin_domII	LAMA2 LAMA5	1.89e-03	5	261	2	IPR010307
Domain	Laminin_aI	LAMA2 LAMA5	1.89e-03	5	261	2	IPR009254
Domain	Laminin_I	LAMA2 LAMA5	1.89e-03	5	261	2	PF06008
Domain	Laminin_II	LAMA2 LAMA5	1.89e-03	5	261	2	PF06009
Domain	D-isomer_DH_NAD-bd	CTBP1 CTBP2	1.89e-03	5	261	2	IPR006140
Domain	DUF4704	WDFY3 LRBA	1.89e-03	5	261	2	IPR031570
Domain	DUF4704	WDFY3 LRBA	1.89e-03	5	261	2	PF15787
Domain	P-loop_NTPase	ABCC3 MFHAS1 MCM7 SRCAP DDX5 MDN1 STARD9 AK1 KIFC3 MYO18B DNAH5 GNL1 KIF11 CACNB1 KIF23 NWD1 LONP2 MYH7B GAL3ST4 LRRK1 ABCB10 MCM9 HELZ2	1.90e-03	848	261	23	IPR027417
Domain	EGF	LRP8 FAT2 NRXN1 NRXN2 HSPG2 HBEGF LRP5	1.98e-03	126	261	7	PF00008
Domain	Fibrinogen_CS	ANGPT4 ANGPTL6 ANGPTL4	2.21e-03	19	261	3	IPR020837
Domain	LDLR_class-A_CS	LRP8 HSPG2 MAMDC4 LRP5	2.29e-03	40	261	4	IPR023415
Domain	Kinesin_motor_CS	STARD9 KIFC3 KIF11 KIF23	2.51e-03	41	261	4	IPR019821
Domain	DUF3669_Znf	ZNF398 ZNF746	2.81e-03	6	261	2	IPR022137
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	ABCC3 TRPM4 MYCBP2 MFHAS1 SPEG FYCO1 SFI1 SRCAP NPHP4 ACOX3 MDN1 TMEM132A ZNF398 MICAL3 KIFC3 PLEC SIPA1L2 DMWD RGL2 MED12 TBCD HSPG2 SHROOM3 LRFN1 FOSL2 NOB1 LAMA5 LRRK1 HUWE1 ADGRA2 IFNLR1 SLC25A22 INF2 KANK3 CSPG4 EIF4G1 HELZ2 LRP5 PKN1 WDFY3 LRBA FUT1 SUFU KLHL17	1.01e-18	1105	275	44	35748872
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	NES MYCBP2 SPTBN1 PAK6 PTPN3 PTPN14 MDN1 STARD9 SIK2 AFDN PLEC SIPA1L2 RGL2 MAP4K4 KLC3 KIF11 CCDC102A PML MIIP RBM15 SHROOM3 KIF23 ARHGEF5 MINK1 PARD3B KLC4 TIAM1 SH3PXD2A EIF4G1 DOCK7 PEAK1 MTSS2	5.05e-13	861	275	32	36931259
Pubmed	Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members.	CDH26 PCDH12 FAT2 PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA4 PCDHB7 PCDHGB4 PCDH8	1.09e-12	77	275	12	10835267
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	CBLL1 TNIK RABEP2 NES MYCBP2 TRPC4 SPTBN1 FYCO1 ARMCX4 CCDC177 PTK2 MDN1 NRXN1 AFDN MAP4K4 KIF11 CACNB1 SHROOM3 KIF23 LRFN1 MINK1 HUWE1 SLC1A3 TRIM3 EIF4G1 DOCK7 SAFB2 CTBP1 CTBP2 PKN1 WDFY3 PCDH8 MTSS2	1.93e-12	963	275	33	28671696
Pubmed	A striking organization of a large family of human neural cadherin-like cell adhesion genes.	PCDH12 FAT2 PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA4 PCDHB7 PCDHGB4 PCDH8	1.22e-11	72	275	11	10380929
Pubmed	Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes.	PCDH12 FAT2 PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA4 PCDHB7 PCDHGB4 PCDH8	4.00e-11	80	275	11	10716726
Pubmed	Cadherin superfamily genes: functions, genomic organization, and neurologic diversity.	PCDH12 PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA4 PCDHB7 PCDHGB4 PCDH8	3.73e-10	74	275	10	10817752
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	STARD13 NES MYCBP2 RPS5 SPTBN1 ZNF185 MCM7 PFKL PHF8 SRCAP PTK2 DDX5 PTPN14 MDN1 AFDN PLEC MED12 KIF11 H1-10 RBM15 KIF23 RNF31 POLD1 NOB1 SAE1 HUWE1 SLC25A22 SLX9 GTF3C1 INF2 EIF4G1 SAFB2 CTBP2 WDFY3	3.16e-09	1353	275	34	29467282
Pubmed	Comparative DNA sequence analysis of mouse and human protocadherin gene clusters.	PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA4 PCDHB7 PCDHGB4 PCDH8	3.48e-09	68	275	9	11230163
Pubmed	The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.	ASXL1 KLHL24 SPTBN1 TRPS1 MCM7 PTPN14 PLEC DNAH5 ANK1 FOSL2 SAE1 HUWE1 EXOC8 ABCB10 EIF4G1 HELZ2	1.17e-08	332	275	16	37433992
Pubmed	Functional proteomics mapping of a human signaling pathway.	STARD13 MYCBP2 LEMD3 SPTBN1 PFKL ACOX3 KANK1 AFDN PLEC TBCD HSPG2 LAMA5 HUWE1 PIR ZNF251 MED4 CSPG4 EIF4G1 LRP5 CTBP2 LZTS2	1.32e-08	591	275	21	15231748
Pubmed	Impaired plasma membrane localization of ubiquitin ligase complex underlies 3-M syndrome development.	TRPS1 PHF8 YTHDC1 DCAF8L1 CROCC2 SIK2 PLEC MYO18B SIPA1L2 RBM15 SHROOM3 KIF23 NOP53 POLD1 PCLO LAMA5 HUWE1 PWP1 ATP6V0A2	2.03e-08	496	275	19	31343991
Pubmed	The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.	TNIK ABCC3 TRPM4 LEMD3 SCARF2 PAK6 LRP8 PTPN3 AMER2 PTPN14 MICAL3 MAP4K4 RELCH MINK1 GAL3ST4 SLC1A3 CSPG4 DOCK7 LRBA PEAK1	3.54e-08	569	275	20	30639242
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	STARD13 TTC16 RPS5 SPTBN1 SRCAP DDX5 MDN1 NRXN1 STARD9 AK1 TTLL1 PLEC SIPA1L2 DMWD KIF11 PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 ZSWIM5 MYH7B PCDHGA4 PCLO RDH12 SLC25A22 RGS14 GTF3C1 SH3PXD2A CSPG4 EIF4G1 PCDHGB4 SAFB2	5.10e-08	1442	275	33	35575683
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	MYCBP2 SPTBN1 PHF8 YTHDC1 MDN1 AFDN MICAL3 PLEC DMWD MAP4K4 CUL4B H1-10 RBM15 KIF23 FOSL2 MINK1 HUWE1 PWP1 GTF3C1 EIF4G1 HELZ2 SAFB2 PKN1	7.02e-08	774	275	23	15302935
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	RABEP2 DCHS2 SPEG SPTBN1 MDN1 CROCC2 MICAL3 MAP4K4 MED12 RBM15 NWD1 ANK1 POLD1 CASP9 DNAI1 GTF3C1 SLC25A10 LRBA	1.12e-07	497	275	18	36774506
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	TNIK ASXL1 MYCBP2 PHF8 NRXN1 NRXN2 SIK2 CACNA1G CUL4B ADGRA2 HELZ2 WDFY3	2.76e-07	225	275	12	12168954
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	CBLL1 RPS5 SPTBN1 ZNF185 EVPL MCM7 PFKL YTHDC1 DDX5 PTPN1 PTPN3 PTPN14 PLEC KIF11 PML H1-10 RBM15 KIF23 NOP53 NOB1 PWP1 SLC25A22 SLX9 GTF3C1 EIF4G1 HELZ2 DOCK7 SAFB2 LZTS2	2.96e-07	1257	275	29	36526897
Pubmed	A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.	TNIK LEMD3 LRP8 PTPN14 PCDH19 MICAL3 SIPA1L2 MAP4K4 CCDC28A MINK1 PARD3B INF2 CTBP1 LRBA PEAK1 MTSS2	3.03e-07	421	275	16	36976175
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	NES MYCBP2 RPS5 SPTBN1 MDN1 AFDN PLEC MED12 CUL4B H1-10 RBM15 KIF23 NOP53 HUWE1 SIRT7 PWP1 GTF3C1 EIF4G1 HELZ2 DOCK7	3.21e-07	653	275	20	22586326
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	CBLL1 TRPM4 LEMD3 TRPS1 PFKL YTHDC1 MDN1 INTS2 TNRC6A AFDN MED12 CERS2 CNOT11 SHROOM3 LONP2 NOP53 POLD1 FOSL2 MINK1 PCDHB7 LAMA5 SIRT7 PWP1 MED4 SLC25A10 EIF4G1 HELZ2 CTBP1 CTBP2 LZTS2 CROCC ATP6V0A2	3.77e-07	1497	275	32	31527615
Pubmed	Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking.	SPTBN1 PFKL SRCAP DDX5 MDN1 PLEC KIF11 KIF23 POLD1 SAE1 HUWE1 GTF3C1 EIF4G1 SAFB2	4.92e-07	332	275	14	32786267
Pubmed	Network organization of the huntingtin proteomic interactome in mammalian brain.	TNIK CDH26 SPTBN1 MCM7 PFKL PTK2 DDX5 ATP8A1 MAP4K4 GNL1 ANK1 PCLO MINK1 HUWE1 SLC1A3 TRIM3 SLC25A22 CTBP1 ATP6V0A2	6.48e-07	621	275	19	22794259
Pubmed	Defining the membrane proteome of NK cells.	GAK MYCBP2 RPS5 MCM7 FYCO1 PFKL ACOX3 DDX5 LRP8 MDN1 ATP8A1 INTS2 ETNK1 MED12 ALG1 KIF11 CERS2 PPP1R21 LONP2 POLD1 HUWE1 EXOC8 MED4 GTF3C1 EIF4G1 HELZ2 LRBA	7.50e-07	1168	275	27	19946888
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	LEMD3 SCARF2 RPS5 MCM7 ARFIP2 PTPN1 PTPN3 NCBP2AS2 TNRC6A AFDN SHROOM3 KIF23 NOP53 MINK1 HUWE1 DOCK7 CTBP1 PKN1 LRBA PEAK1 ATP6V0A2	1.22e-06	777	275	21	35844135
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	TNIK PKD1L1 ZNF185 PHF8 ARFIP2 PTPN14 MVB12A TNRC6A AFDN MICAL3 MINDY4 PLEC SIPA1L2 MAP4K4 CUL4B SHROOM3 NOB1 CASP9 PARD3B KLC4 MED4 SUFU	1.45e-06	853	275	22	28718761
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	MYCBP2 TRPS1 MCM7 TRIM24 TNRC6A PLEC MED12 KIF11 NPAT HUWE1 GTF3C1 DOCK7 CTBP1 CTBP2 LRBA	1.46e-06	418	275	15	34709266
Pubmed	ZNF750 interacts with KLF4 and RCOR1, KDM1A, and CTBP1/2 chromatin regulators to repress epidermal progenitor genes and induce differentiation genes.	ZNF185 PPP1R21 CTBP1 CTBP2 LRBA	1.71e-06	26	275	5	25228645
Pubmed	The Ikaros family protein Eos associates with C-terminal-binding protein corepressors.	TRPS1 CTBP1 CTBP2	1.94e-06	4	275	3	12444977
Pubmed	Axoglial synapses are formed onto pioneer oligodendrocyte precursor cells at the onset of spinal cord gliogenesis.	NES SLC1A3 CSPG4	1.94e-06	4	275	3	29603384
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	GAK MYCBP2 DACH1 MCM7 PHF8 SRCAP PTPN14 AFDN MAP4K4 MED12 KIF23 HUWE1 GTF3C1 DOCK7 LRBA PEAK1 LZTS2	2.17e-06	549	275	17	38280479
Pubmed	Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma.	TNIK LEMD3 SCARF2 SPTBN1 PTPN3 PTPN14 MAP4K4 MINK1 PARD3B TIAM1 CSPG4 DOCK7 PEAK1 LZTS2	2.20e-06	377	275	14	38117590
Pubmed	Comprehensive identification of phosphorylation sites in postsynaptic density preparations.	LEMD3 SPEG SPTBN1 AMER2 CACNB1 ANK1 PCLO TRIM3 TIAM1 SAFB2 PEAK1	2.62e-06	231	275	11	16452087
Pubmed	The protein interaction landscape of the human CMGC kinase group.	CDKN2D ASXL1 TRPS1 MCM7 YTHDC1 PTK2 DDX5 DMBT1 SIPA1L2 MED12 CACNB1 RBM15 CNOT11 CCDC28A HUWE1 MED4 RIMS4 CTBP2 LZTS2	3.37e-06	695	275	19	23602568
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	RABEP2 MYCBP2 LEMD3 SPTBN1 TRPS1 PHF8 PTPN1 PTPN3 PTPN14 TNRC6A MICAL3 DMWD RELCH RBM15 NOP53 MINK1 HUWE1 PPM1K CCDC61 MED4 TIAM1 PEAK1 LZTS2 SUFU	3.79e-06	1049	275	24	27880917
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	MYCBP2 SPTBN1 PTK2 AMER2 ATP8A1 MICAL3 PLEC SIPA1L2 CACNB1 PCLO MINK1 SLC1A3 SH3PXD2A	4.62e-06	347	275	13	17114649
Pubmed	∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis.	SPTBN1 MCM7 PFKL MDN1 COG6 PLEC ALG1 H1-10 MYH7B NOP53 SAE1 LAMA5 HUWE1 EXOC8 ABCB10 SLC25A10 CTBP2 LRBA	4.82e-06	647	275	18	26618866
Pubmed	Maturation of postnatally generated olfactory bulb granule cells depends on functional γ-protocadherin expression.	PCDHGB2 PCDHGA11 PCDHGA4 PCDHGB4	4.87e-06	15	275	4	23515096
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	ERCC4 PFKL PTK2 SIK2 AFDN MICAL3 MAP4K4 DDX11L8 ALG1 RNF31 LONP2 ARHGEF5 MINK1 EXOC8 PWP1 GTF3C1 SLC25A10 DOCK7	5.13e-06	650	275	18	38777146
Pubmed	A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins.	CBLL1 ABCC3 TRPM4 ZNF185 ARFIP2 LRP8 PTPN3 TNRC6A AFDN TMCO3 MAP4K4 TBCD KIF11 NOB1 PARD3B ABCB10 SLC25A10 LRBA PEAK1	5.46e-06	719	275	19	35337019
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	CBLL1 NES MYCBP2 RPS5 SPTBN1 SRCAP YTHDC1 DDX5 NRXN1 NRXN2 PLEC SIPA1L2 MAP4K4 MED12 RBM15 CCDC61 PWP1 GTF3C1 SLC25A10 EIF4G1 HELZ2 DOCK7 SAFB2 CTBP1	6.37e-06	1082	275	24	38697112
Pubmed	USP7 controls NGN3 stability and pancreatic endocrine lineage development.	RPS5 SPEG SPTBN1 PLEC HUWE1 GTF3C1	6.63e-06	58	275	6	37117185
Pubmed	Human GW182 Paralogs Are the Central Organizers for RNA-Mediated Control of Transcription.	NES TRIM24 TNRC6A MED12 CNOT11 MED4	7.34e-06	59	275	6	28813667
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	STARD13 RABEP2 MYCBP2 MCM7 NPHP4 DDX5 PTPN14 NRXN1 AFDN MINDY4 PLEC KLC3 TBCD CUL4B RELCH CNOT11 LRFN1 LONP2 POLD1 KLC4 EXOC8 MED4 TIAM1 SH3PXD2A DOCK7 CTBP1 CTBP2	7.36e-06	1321	275	27	27173435
Pubmed	Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.	STARD13 MYCBP2 SPTBN1 MCM7 FYCO1 SRCAP DDX5 PTPN1 MDN1 CACNA1G PLEC CERS2 H1-10 PCLO HUWE1 PIR SLC25A10 EIF4G1 LRBA PEAK1	7.93e-06	807	275	20	30575818
Pubmed	Laminin α1 is essential for mouse cerebellar development.	NES PTK2 LAMA2 LAMA5	8.39e-06	17	275	4	21983115
Pubmed	Comparative interactome analysis of α-arrestin families in human and Drosophila.	TNIK MCM7 MAP4K4 RBM15 RNF31 POLD1 LAMA5 HUWE1 TRIM3 GTF3C1 DOCK7 ATP6V0A2	8.54e-06	313	275	12	38270169
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	RPS5 SPTBN1 MCM7 PFKL DDX5 PTPN1 MDN1 STARD9 AFDN MYO18B DNAH5 MAP4K4 KIF11 H1-10 RBM15 KIF23 NOP53 POLD1 PCLO HUWE1 PWP1 SLC25A22 GTF3C1 EIF4G1 DOCK7 SAFB2 CTBP2 PEAK1	1.02e-05	1425	275	28	30948266
Pubmed	Human transcription factor protein interaction networks.	ASXL1 ERCC4 RPS5 SPTBN1 TRPS1 DACH1 PHF8 SRCAP TRIM24 TNRC6A PML NPAT ASNSD1 HSPG2 H1-10 CNOT11 KIF23 NOP53 PWP1 ANGPTL6 MED4 GTF3C1 ZNF746 SLC25A10 EIF4G1 CTBP1 CTBP2 SUFU	1.08e-05	1429	275	28	35140242
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	NES GAK RPS5 SPTBN1 ZNF185 PFKL CCDC177 PGM1 DDX5 ATP8A1 NRXN2 AFDN MICAL3 PLEC SIPA1L2 MICAL1 PCLO MINK1 SLC1A3 TRIM3 SLC25A22 TARS3 INF2 EIF4G1 DOCK7 CTBP1 PEAK1 CROCC	1.10e-05	1431	275	28	37142655
Pubmed	Systematic proteomics of endogenous human cohesin reveals an interaction with diverse splicing factors and RNA-binding proteins required for mitotic progression.	SPTBN1 DDX5 MDN1 INTS2 DMBT1 PLEC MED12 RBM15 KIF23 GTF3C1 ANGPTL4	1.24e-05	272	275	11	31010829
Pubmed	E-cadherin interactome complexity and robustness resolved by quantitative proteomics.	SPTBN1 ZNF185 EVPL EPS8L1 PAK6 ARFIP2 PTPN1 AFDN PLEC H1-10 SHROOM3 MINK1 EIF4G1 LRATD2 PEAK1 LZTS2	1.31e-05	565	275	16	25468996
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	TNIK MYCBP2 SPTBN1 PFKL PTPN1 AMER2 NRXN1 TNRC6A AK1 AFDN PLEC SIPA1L2 MAP4K4 CACNB1 RELCH OGFR PCLO ADCK1 MINK1 HUWE1 SLC1A3 DOCK7 PEAK1 PCDH8	1.48e-05	1139	275	24	36417873
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	SDE2 MYCBP2 LEMD3 SRCAP MICAL3 MED12 KIF11 RBM15 CNOT11 KIF23 HUWE1 CCDC61 MED4 DOCK7 CTBP1 CTBP2 LRBA	1.77e-05	645	275	17	25281560
Pubmed	Prediction of the coding sequences of unidentified human genes. XVII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	TNRC6A RELCH SHROOM3 LRFN1 ZSWIM5 MYH7B ADGRA2	1.86e-05	103	275	7	10819331
Pubmed	Human Immunodeficiency Virus Type 1 Vpr Mediates Degradation of APC1, a Scaffolding Component of the Anaphase-Promoting Complex/Cyclosome.	MYCBP2 LEMD3 INTS2 TNRC6A SIPA1L2 MED12 CNOT11 NOP53 POLD1 LRBA	2.56e-05	242	275	10	34011540
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	CBLL1 MCM7 ZNF831 YTHDC1 INTS2 TNRC6A PML CUL4B NOP53 PARD3B HUWE1 ZMAT3 GTF3C1 CTBP1	2.58e-05	469	275	14	27634302
Pubmed	Mapping genetic modulators of amyloid plaque deposition in TgCRND8 transgenic mice.	ABCC3 RNF130 HSPG2	2.66e-05	8	275	3	16785251
Pubmed	Phosphoproteomic analysis of the developing mouse brain.	TNIK NES SPTBN1 AMER2 MAP4K4 HUWE1 EXOC8 PWP1 SAFB2 PKN1	2.94e-05	246	275	10	15345747
Pubmed	N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.	RABEP2 NES GAK SPTBN1 EVPL PGM1 COG6 MICAL3 PLEC PML RBM15 EIF4G1	3.39e-05	360	275	12	33111431
Pubmed	Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation.	CBLL1 MYCBP2 RPS5 SPTBN1 NPHP4 DDX5 STARD9 PLEC ASNSD1 RBM15 PWP1 PEAK1	3.49e-05	361	275	12	30344098
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	MYCBP2 PKD1L1 EPS8L1 YTHDC1 HMCN2 MYO18B KIF11 RBM15 KIF23 NOP53 ASXL3 EIF4G1	3.49e-05	361	275	12	26167880
Pubmed	The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery.	CBLL1 ERCC4 LEMD3 SPTBN1 MCM7 YTHDC1 DDX5 INTS2 TMEM132A AFDN PLEC MED12 ALG1 TBCD PML CERS2 GALNT14 H1-10 EXOC8 ABCB10 CSPG4 EIF4G1 DOCK7 SAFB2	3.55e-05	1203	275	24	29180619
Pubmed	HSF1 phosphorylation establishes an active chromatin state via the TRRAP-TIP60 complex and promotes tumorigenesis.	SCARF2 SPTBN1 TRIM24 DDX5 LRFN4 CACNA1G TMCO3 DMBT1 ASNSD1 PPP1R21 RBM15 SHROOM3 LRFN1 LAMA5 SLC1A6 SLC25A22 EIF4G1 SAFB2	3.69e-05	754	275	18	35906200
Pubmed	Non-erythroid beta spectrin interacting proteins and their effects on spectrin tetramerization.	SPTBN1 NOP53 ZNF251	3.97e-05	9	275	3	21866423
Pubmed	PDZ-domain-mediated interaction of the Eph-related receptor tyrosine kinase EphB3 and the ras-binding protein AF6 depends on the kinase activity of the receptor.	NRXN1 NRXN2 AFDN	3.97e-05	9	275	3	9707552
Pubmed	Molecular mechanisms governing Pcdh-gamma gene expression: evidence for a multiple promoter and cis-alternative splicing model.	PCDHGB2 PCDHGA11 PCDHGB4	3.97e-05	9	275	3	12154121
Pubmed	Proteomic, functional, and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization.	MYCBP2 SPTBN1 PTPN14 AFDN KLC3 KIF23 PARD3B KLC4 TIAM1 DOCK7	3.98e-05	255	275	10	15324660
Pubmed	Temporal patterning of apical progenitors and their daughter neurons in the developing neocortex.	NES TRPS1 DACH1 LRP8 PCDH19 SLC1A3	4.90e-05	82	275	6	31073041
Pubmed	Primary cellular meningeal defects cause neocortical dysplasia and dyslamination.	NES LAMA2 LAMA5	5.63e-05	10	275	3	20976766
Pubmed	Angiogenic sprouting into neural tissue requires Gpr124, an orphan G protein-coupled receptor.	NES ADGRA2 CSPG4	5.63e-05	10	275	3	21282641
Pubmed	Cytoplasmic Metadherin (MTDH) provides survival advantage under conditions of stress by acting as RNA-binding protein.	ABCC3 PLEC DNAH5 TBCD HSPG2 LAMA5 ADGRA2 LRP5 PKN1	5.66e-05	214	275	9	22199357
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	TNIK GAK MYCBP2 LEMD3 SPTBN1 TRIM24 PTPN1 PTPN14 MDN1 SIK2 SIPA1L2 MAP4K4 PML NPAT H1-10 SHROOM3 POLD1 MINK1 CCDC61 SLX9 MED4 ABCB10 TIAM1 INF2 PEAK1 LZTS2 ATP6V0A2	5.75e-05	1487	275	27	33957083
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	RNF130 TRPM4 CDH26 MYCBP2 TRPS1 PFKL PTK2 LRP8 INTS2 MICAL3 TBCD SHROOM3 FOSL2 MINK1 PARD3B HUWE1 PPM1K GTF3C1 INF2 SH3PXD2A LRP5 CTBP1 CTBP2 PKN1 LRBA LZTS2 CROCC	5.88e-05	1489	275	27	28611215
Pubmed	Loss of cerebellar glutamate transporters EAAT4 and GLAST differentially affects the spontaneous firing pattern and survival of Purkinje cells.	SLC1A3 SLC1A6	6.23e-05	2	275	2	29741614
Pubmed	Activation of anaplastic lymphoma kinase is responsible for hyperphosphorylation of ShcC in neuroblastoma cell lines.	SHC3 ALK	6.23e-05	2	275	2	12185581
Pubmed	The expression pattern of laminin isoforms in Hirschsprung disease reveals a distal peripheral nerve differentiation.	LAMA2 LAMA5	6.23e-05	2	275	2	16226104
Pubmed	The balance between KIFC3 and EG5 tetrameric kinesins controls the onset of mitotic spindle assembly.	KIFC3 KIF11	6.23e-05	2	275	2	31481795
Pubmed	C-Terminal Binding Protein is Involved in Promoting to the Carcinogenesis of Human Glioma.	CTBP1 CTBP2	6.23e-05	2	275	2	27699603
Pubmed	Mutations in NRXN1 and NRXN2 in a patient with early-onset epileptic encephalopathy and respiratory depression.	NRXN1 NRXN2	6.23e-05	2	275	2	30709877
Pubmed	SIRT7 promotes the proliferation and migration of anaplastic thyroid cancer cells by regulating the desuccinylation of KIF23.	KIF23 SIRT7	6.23e-05	2	275	2	38360598
Pubmed	Regulation of melastatin, a TRP-related protein, through interaction with a cytoplasmic isoform.	TRPM4 TRPM1	6.23e-05	2	275	2	11535825
Pubmed	Differential roles of glial and neuronal glutamate transporters in Purkinje cell synapses.	SLC1A3 SLC1A6	6.23e-05	2	275	2	16177048
Pubmed	Molecular cloning and characterization of a cellular phosphoprotein that interacts with a conserved C-terminal domain of adenovirus E1A involved in negative modulation of oncogenic transformation.	CTBP1 CTBP2	6.23e-05	2	275	2	7479821
Pubmed	MICAL3 Flavoprotein Monooxygenase Forms a Complex with Centralspindlin and Regulates Cytokinesis.	MICAL3 KIF23	6.23e-05	2	275	2	27528609
Pubmed	HUWE1 ubiquitylates and degrades the RAC activator TIAM1 promoting cell-cell adhesion disassembly, migration, and invasion.	HUWE1 TIAM1	6.23e-05	2	275	2	25543140
Pubmed	Skeletal muscle neural progenitor cells exhibit properties of NG2-glia.	NES CSPG4	6.23e-05	2	275	2	22999866
Pubmed	Glutamate transporters GLAST and EAAT4 regulate postischemic Purkinje cell death: an in vivo study using a cardiac arrest model in mice lacking GLAST or EAAT4.	SLC1A3 SLC1A6	6.23e-05	2	275	2	16647773
Pubmed	Rootletin, a novel coiled-coil protein, is a structural component of the ciliary rootlet.	KLC3 CROCC	6.23e-05	2	275	2	12427867
Pubmed	Assembly of human C-terminal binding protein (CtBP) into tetramers.	CTBP1 CTBP2	6.23e-05	2	275	2	29700119
Pubmed	Cell surface chondroitin sulphate proteoglycan 4 (CSPG4) binds to the basement membrane heparan sulphate proteoglycan, perlecan, and is involved in cell adhesion.	HSPG2 CSPG4	6.23e-05	2	275	2	29462330
Pubmed	KANK family proteins in cancer.	KANK1 KANK3	6.23e-05	2	275	2	33309958
Pubmed	NAD(H) phosphates mediate tetramer assembly of human C-terminal binding protein (CtBP).	CTBP1 CTBP2	6.23e-05	2	275	2	33524397
Pubmed	Expression of CtBP family protein isoforms in breast cancer and their role in chemoresistance.	CTBP1 CTBP2	6.23e-05	2	275	2	20964627
Pubmed	Heterozygous deletion of α-neurexin I or α-neurexin II results in behaviors relevant to autism and schizophrenia.	NRXN1 NRXN2	6.23e-05	2	275	2	26595880
Pubmed	NADH/NAD+ binding and linked tetrameric assembly of the oncogenic transcription factors CtBP1 and CtBP2.	CTBP1 CTBP2	6.23e-05	2	275	2	34997967
Pubmed	Angiopoietin-like 4 (Angptl4) protein is a physiological mediator of intracellular lipolysis in murine adipocytes.	ANGPT4 ANGPTL4	6.23e-05	2	275	2	22267746
Pubmed	Congenital heart disease and other heterotaxic defects in a large cohort of patients with primary ciliary dyskinesia.	DNAH5 DNAI1	6.23e-05	2	275	2	17515466
Pubmed	F-circEA1 regulates cell proliferation and apoptosis through ALK downstream signaling pathway in non-small cell lung cancer.	ERCC4 ALK	6.23e-05	2	275	2	34633654
Pubmed	Molecular cloning and functional characterization of brefeldin A-ADP-ribosylated substrate. A novel protein involved in the maintenance of the Golgi structure.	CTBP1 CTBP2	6.23e-05	2	275	2	10364211
Interaction	TOP3B interactions	ABCC3 TRPM4 MYCBP2 MFHAS1 SPEG FYCO1 SFI1 PFKL SRCAP NPHP4 ACOX3 MDN1 TMEM132A ZNF398 MICAL3 KIFC3 PLEC SIPA1L2 DMWD RGL2 MED12 TBCD HSPG2 RBM15 CNOT11 SHROOM3 KIF23 LRFN1 FOSL2 NOB1 LAMA5 LRRK1 HUWE1 ADGRA2 IFNLR1 SLC25A22 INF2 KANK3 CSPG4 EIF4G1 HELZ2 SAFB2 LRP5 PKN1 WDFY3 LRBA FUT1 SUFU KLHL17	3.23e-09	1470	272	49	int:TOP3B
Interaction	PCDHA9 interactions	LRFN1 PCDHGB7 PCDHGB6 PCDHGB2 PCDHGA11 LONP2 PCDHGA4	1.90e-07	32	272	7	int:PCDHA9
Interaction	YWHAH interactions	NES MYCBP2 SPEG SPTBN1 PAK6 PTPN3 KANK1 PTPN14 STARD9 SIK2 AFDN PLEC SIPA1L2 DMWD RGL2 MAP4K4 KLC3 KIF11 MIIP RBM15 SHROOM3 KIF23 ARHGEF5 MINK1 PARD3B HUWE1 KLC4 SLX9 TIAM1 SH3PXD2A DENND2C EIF4G1 DOCK7 LRBA PEAK1 MTSS2	8.37e-07	1102	272	36	int:YWHAH
Interaction	YWHAG interactions	MYCBP2 SPEG SPTBN1 PAK6 PTK2 PTPN3 KANK1 LRFN4 PTPN14 MDN1 STARD9 SIK2 AFDN SIPA1L2 DMWD RGL2 MAP4K4 KLC3 CCDC102A MIIP RBM15 SHROOM3 KIF23 RNF31 ARHGEF5 MINK1 SH2D3C PARD3B HUWE1 KLC4 TIAM1 SH3PXD2A DENND2C EIF4G1 DOCK7 LRBA PEAK1 LZTS2 MTSS2	8.41e-07	1248	272	39	int:YWHAG
Interaction	YWHAZ interactions	ASXL1 MYCBP2 SPEG SPTBN1 PFKL PAK6 PTPN3 KANK1 PTPN14 NRXN1 STARD9 SIK2 AFDN PLEC SIPA1L2 DMWD KLC3 KIF11 PML MIIP RBM15 SHROOM3 KIF23 ARHGEF5 MINK1 SH2D3C PARD3B HUWE1 KLC4 SLC1A3 TRIM3 EXOC8 MCTP1 TIAM1 SH3PXD2A ASXL3 DOCK7 WDFY3 PEAK1 MTSS2	1.27e-06	1319	272	40	int:YWHAZ
Interaction	SIPA1L1 interactions	STARD13 TNIK PTPN14 NRXN1 AFDN SIPA1L2 LRFN1 GARNL3 POLD1 TIAM1 SH3PXD2A LZTS2	4.51e-06	174	272	12	int:SIPA1L1
Interaction	SH2D2A interactions	MFHAS1 PLEKHB1 PTK2 PPP1R21 LRRK1 TENT5B PEAK1	6.01e-06	52	272	7	int:SH2D2A
Interaction	KIF5A interactions	TNIK RABEP2 COG6 MICAL3 MAP4K4 KLC3 KIF11 KLC4 MED4	7.19e-06	98	272	9	int:KIF5A
Interaction	ANK3 interactions	TNIK SPTBN1 MICAL3 PLEC KIF11 H1-10 PWP1 RGS14 TIAM1 DOCK7 PEAK1 LZTS2	1.95e-05	201	272	12	int:ANK3
Interaction	MEX3A interactions	ASXL1 KLHL24 SPTBN1 TRPS1 MCM7 PTPN14 PLEC DNAH5 ANK1 FOSL2 LAMA2 SAE1 HUWE1 EXOC8 ABCB10 EIF4G1 HELZ2	2.01e-05	384	272	17	int:MEX3A
Interaction	YWHAQ interactions	CBLL1 MYCBP2 SPEG PFKL PAK6 PTPN3 KANK1 PTPN14 NRXN1 STARD9 SIK2 AFDN PLEC SIPA1L2 DMWD RGL2 KLC3 TBCD MIIP SHROOM3 KIF23 ARHGEF5 MINK1 PARD3B KLC4 TIAM1 SH3PXD2A DENND2C EIF4G1 DOCK7 LRBA PEAK1 MTSS2	2.06e-05	1118	272	33	int:YWHAQ
Interaction	SFN interactions	TNIK MYCBP2 SPTBN1 DDX5 PTPN3 PTPN14 SIK2 PLEC SIPA1L2 MAP4K4 MIIP SHROOM3 KIF23 POLD1 ARHGEF5 MINK1 PARD3B KLC4 TIAM1 SH3PXD2A EIF4G1 DOCK7 PEAK1 MTSS2	2.47e-05	692	272	24	int:SFN
Interaction	PCDHGB2 interactions	PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGB4	2.63e-05	44	272	6	int:PCDHGB2
Interaction	ZNF750 interactions	ZNF185 PPP1R21 CTBP1 CTBP2 LRBA	3.29e-05	28	272	5	int:ZNF750
Interaction	EPHB2 interactions	TNIK MYCBP2 PTK2 MDN1 AFDN MAP4K4 ALK KIF23 SH2D3C SLC1A3 LRBA PEAK1	3.95e-05	216	272	12	int:EPHB2
Interaction	ZNF785 interactions	YTHDC1 TRIM24 KIFC3 RNF31 GTF3C1 DOCK7 LZTS2 SUFU	4.38e-05	95	272	8	int:ZNF785
Interaction	PCDHGB7 interactions	PCDHGB7 PCDHGB2 PCDHGA4	4.72e-05	6	272	3	int:PCDHGB7
Interaction	YWHAB interactions	MYCBP2 SPEG SPTBN1 PAK6 PTPN3 KANK1 LRFN4 PTPN14 STARD9 SIK2 AFDN SIPA1L2 DMWD RGL2 KLC3 MIIP SHROOM3 KIF23 POLD1 ARHGEF5 MINK1 PARD3B KLC4 TIAM1 SH3PXD2A DENND2C EIF4G1 DOCK7 PEAK1 MTSS2	4.82e-05	1014	272	30	int:YWHAB
Interaction	AFDN interactions	PAK6 PTPN14 NRXN1 NRXN2 TNRC6A AFDN SIPA1L2 MAP4K4 SHROOM3 LRFN1 MINK1 SIRT7 SH3PXD2A PEAK1 LZTS2	5.09e-05	333	272	15	int:AFDN
Interaction	LIMK1 interactions	MFHAS1 PAK6 MIIP KIF23 LONP2 SLC25A22 RNF6 CTBP1	5.09e-05	97	272	8	int:LIMK1
Interaction	FAM184A interactions	TNRC6A SIPA1L2 CUL4B LRRK1 CCDC61 MED4 LZTS2	5.26e-05	72	272	7	int:FAM184A
Interaction	DCLK1 interactions	STARD13 TNIK MYCBP2 MCM7 PTPN14 AFDN LRFN1 TIAM1 SH3PXD2A	5.76e-05	127	272	9	int:DCLK1
Interaction	PCDHGB1 interactions	LEMD3 PCDH19 LRFN1 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGB4	8.11e-05	77	272	7	int:PCDHGB1
Interaction	OBSL1 interactions	NES MCM7 PHF8 SRCAP YTHDC1 DDX5 MDN1 CROCC2 SIK2 AFDN PLEC SIPA1L2 MAP4K4 H1-10 RBM15 SHROOM3 KIF23 NOP53 POLD1 PCLO LAMA5 HUWE1 PWP1 ARHGEF35 GTF3C1 SAFB2 ATP6V0A2	9.66e-05	902	272	27	int:OBSL1
Interaction	PCDHGA10 interactions	SPTBN1 PCDHGB2 PCDHGA4 PCDHB7	1.07e-04	19	272	4	int:PCDHGA10
Interaction	PCDHGB3 interactions	PCDHGB3 PCDHGB2 PCDHGB4	1.30e-04	8	272	3	int:PCDHGB3
Cytoband	5q31	PCDH12 PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA4 PCDHB7 PCDHGB4	3.52e-08	115	275	9	5q31
Cytoband	Ensembl 112 genes in cytogenetic band chr5q31	PCDH12 PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA4 HBEGF PCDHB7 PCDHGB4	1.46e-05	298	275	10	chr5q31
GeneFamily	Clustered protocadherins	PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA4 PCDHB7 PCDHGB4	3.72e-07	64	192	8	20
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	SPEG LRFN4 HMCN2 HSPG2 LRFN1 MXRA5 SIGLEC16 LINGO4 MDGA1	5.67e-05	161	192	9	593
GeneFamily	PDZ domain containing	PTPN3 AFDN SIPA1L2 SHROOM3 PCLO PARD3B HTRA3 TIAM1	2.23e-04	152	192	8	1220
GeneFamily	Non-clustered protocadherins	PCDH12 PCDH19 PCDH8	2.42e-04	12	192	3	21
GeneFamily	Ankyrin repeat domain containing\|KN motif and ankyrin repeat domain containing	KANK1 KANK3	6.64e-04	4	192	2	623
GeneFamily	Protein tyrosine phosphatases, non-receptor type	PTPN1 PTPN3 PTPN14	8.55e-04	18	192	3	812
GeneFamily	Kinesins\|Pleckstrin homology domain containing	STARD9 KIFC3 KIF11 KIF23	1.42e-03	46	192	4	622
GeneFamily	Blood group antigens\|CD molecules\|Proteoglycans	HSPG2 CSPG4	2.27e-03	7	192	2	570
GeneFamily	Fibrinogen C domain containing	ANGPT4 ANGPTL6 ANGPTL4	2.28e-03	25	192	3	554
GeneFamily	EF-hand domain containing\|Plakins	EVPL PLEC	3.01e-03	8	192	2	939
GeneFamily	Fibrinogen C domain containing\|Angiopoietin like	ANGPTL6 ANGPTL4	3.01e-03	8	192	2	905
GeneFamily	Transient receptor potential cation channels	TRPM4 TRPC4 TRPM1	3.18e-03	28	192	3	249
GeneFamily	MCM family	MCM7 MCM9	3.85e-03	9	192	2	1085
GeneFamily	WD repeat domain containing\|BEACH domain containing	WDFY3 LRBA	3.85e-03	9	192	2	1230
Coexpression	GSE12392_CD8A_POS_VS_NEG_SPLEEN_DC_DN	CDKN2D ASXL1 SPTBN1 MCM7 PLEC DMWD MAP4K4 KIF11 KIF23 POLD1 SAE1 TIAM1 SLC25A10 LRATD2	2.79e-08	200	274	14	M7143
Coexpression	GSE21360_SECONDARY_VS_TERTIARY_MEMORY_CD8_TCELL_DN	TNIK ABCC3 MCM7 SRCAP ACOX3 PPP1R21 MICAL1 GAL3ST4 LRRK1 KLC4 SLC1A6	1.59e-06	167	274	11	M7621
Coexpression	PRC2_EED_DN.V1_DN	TRPM4 MFHAS1 PCDH12 KCNS1 H1-10 MICAL1 KIF23 POLD1 FOSL2 CSPG4 PEAK1	6.46e-06	193	274	11	M2734
Coexpression	GSE32986_CURDLAN_LOWDOSE_VS_CURDLAN_HIGHDOSE_STIM_DC_UP	CNPY4 MCM7 ACOX3 NCBP2AS2 STARD9 RELCH KIF23 RGS14 MCTP1 CLDND2 ANGPTL4	9.06e-06	200	274	11	M8632
Coexpression	GSE7768_OVA_ALONE_VS_OVA_WITH_MPL_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_UP	ASXL1 GAK MFHAS1 TRPS1 ACOX3 RBM15 KIF23 EIF4G1 SAFB2 CTBP1	2.23e-05	181	274	10	M6857
Coexpression	GSE37301_PRO_BCELL_VS_RAG2_KO_NK_CELL_UP	LRP8 ATP8A1 AFDN PLEC PIGL LONP2 CCDC61 TRIM3 CTBP2 PKN1	2.34e-05	182	274	10	M8899
Coexpression	MIKKELSEN_ES_ICP_WITH_H3K4ME3	RASGRP4 CNPY4 PAK6 NPFFR2 NRXN1 KCND1 NFE2 AK1 KLC3 PML CUL4B MICAL1 APOF LAMA2 RDH12 PIR KLC4 CLDND2 DENND2C FUT1 CROCC	3.02e-05	728	274	21	M2004
Coexpression	DELACROIX_RARG_BOUND_MEF	CDKN2D KLHL24 TNFSF13 SPTBN1 PLEKHB1 DDX5 CAVIN4 DMWD CERS2 H1-10 CACNB1 INF2 CTBP2 PKN1	3.50e-05	366	274	14	M2461
Coexpression	DELACROIX_RARG_BOUND_MEF	CDKN2D KLHL24 TNFSF13 SPTBN1 PLEKHB1 DDX5 CAVIN4 DMWD CERS2 H1-10 CACNB1 INF2 CTBP2 PKN1	4.96e-05	378	274	14	MM1077
Coexpression	GSE32986_GMCSF_AND_CURDLAN_LOWDOSE_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_UP	RNF130 SPTBN1 NCBP2AS2 KIF11 ASNSD1 RELCH CCDC28A KANK3 ZNF746 CTBP1	4.99e-05	199	274	10	M8639
Coexpression	GSE20715_WT_VS_TLR4_KO_24H_OZONE_LUNG_DN	ARMCX4 RGL2 MED12 PPP1R21 CCDC28A HBEGF SH2D3C TRIM3 ANGPTL4 LZTS2	5.21e-05	200	274	10	M4354
Coexpression	EPPERT_HSC_R	ASXL1 SPTBN1 DACH1 PTK2 DDX5 GNL1 LONP2 MCTP1	5.90e-05	127	274	8	M19231
Coexpression	GSE40274_CTRL_VS_FOXP3_AND_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	STARD9 RGL2 PPP1R21 MICAL1 KIF23 HBEGF APOF RGS14 LRP5	7.61e-05	169	274	9	M9102
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TNIK ABCC3 PTK2 PTPN3 KANK1 AFDN MICAL3 KIFC3 GALNT14 SHROOM3 PARD3B	3.73e-08	194	275	11	7002937e8903e037332a215d00fbc7c7843b33f2
ToppCell	control\|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	BICDL2 SPTBN1 EVPL PTPN3 FAT2 AFDN ADGRF1 PCLO LAMA5 SH3PXD2A DENND2C	5.10e-08	200	275	11	97f36d2c197e03d93a1fc59949d77ae90f6e6a9a
ToppCell	IIH-CD8-antiviral_CD4\|IIH / Condition, Cell_class and T cell subcluster	RABEP2 MFHAS1 FYCO1 SFI1 ACOX3 PTPN1 ALG1 IFNLR1 SLC25A22 DENND2C	1.62e-07	177	275	10	fe73608c40701eca88b260aeb5c0640d7bee72ba
ToppCell	droplet-Lung-18m-Mesenchymal-myofibroblast-pericyte_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SPEG LRRC10B PCDH19 LOXL3 PPM1N SHROOM3 HBEGF LAMA2 CSPG4 ANGPTL4	1.80e-07	179	275	10	f5bb4d3a27d56698473219970e764084096cc582
ToppCell	droplet-Lung-18m-Mesenchymal-myofibroblast-pericyte_cell-pericyte\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SPEG LRRC10B PCDH19 LOXL3 PPM1N SHROOM3 HBEGF LAMA2 CSPG4 ANGPTL4	1.80e-07	179	275	10	fa03ec3cc0132f977b4cb28e7b23789732375183
ToppCell	droplet-Lung-nan-18m-Mesenchymal-Pericyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPEG LRRC10B PCDH19 LOXL3 SHROOM3 HBEGF LAMA2 CSPG4 ANGPTL4 MTSS2	1.89e-07	180	275	10	f6a05b3751b01e74b2de8440801b0eb2e723c199
ToppCell	droplet-Lung-nan-18m-Mesenchymal-pericyte_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPEG LRRC10B PCDH19 LOXL3 SHROOM3 HBEGF LAMA2 CSPG4 ANGPTL4 MTSS2	1.89e-07	180	275	10	dfc75ae4395ff46fbec2c54915d98ead5a1ba1a1
ToppCell	TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-6\|TCGA-Breast / Sample_Type by Project: Shred V9	RASGRP4 SCARF2 HMCN2 NRXN2 RAPGEF3 SH2D3C LAMA2 ADGRA2 MCTP1 KANK3	2.83e-07	188	275	10	c90669b51e1902fe7726555290c91c92a911df83
ToppCell	CF-Lymphoid-B_cell\|CF / Disease state, Lineage and Cell class	RABEP2 ASXL1 MYCBP2 MDN1 ATP8A1 MICAL3 PPM1K IFNLR1 PWP1 LRBA	3.13e-07	190	275	10	374d8fd63c733178acab07682ed1519693efab45
ToppCell	human_hepatoblastoma-Tumor_cells\|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells)	ASXL1 TRIM24 PTK2 KANK1 TNRC6A AFDN ZSWIM5 PARD3B LRP5 MTSS2	3.61e-07	193	275	10	503a979328c68b096680b71359a26f02fafdff35
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MFHAS1 PTPN3 KANK1 AFDN KIFC3 GALNT14 SHROOM3 PCLO PARD3B LRBA	3.61e-07	193	275	10	3866667dd221612589ae50f5c52f73a183a49ce6
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PTPN3 KANK1 PTPN14 AFDN KIFC3 GALNT14 SHROOM3 PCLO PARD3B LRBA	3.97e-07	195	275	10	6477e6e7be5bd8eb99119a12ae16334ccddecd43
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	TNIK ABCC3 SPTBN1 DACH1 BMP5 AFDN LAMA2 PARD3B SLC1A3 ASXL3	4.36e-07	197	275	10	0034bae02ee7fcfea520d453ca3c842ab6963b12
ToppCell	Parenchymal-NucSeq\|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations	STARD13 PTK2 KANK1 ATP8A1 ATP13A4 SHROOM3 PARD3B WDFY3 LRBA PEAK1	4.57e-07	198	275	10	1996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	NES SPTBN1 DACH1 PCDH12 PTK2 AFDN SIPA1L2 RGL2 SH2D3C MCTP1	5.01e-07	200	275	10	79e51afb57ca38aacebd0298e5e727b55c0cfff9
ToppCell	Control_saline-Endothelial-Endothelial\|Control_saline / Treatment groups by lineage, cell group, cell type	SPTBN1 DACH1 PCDH12 PTK2 AFDN PLEC SIPA1L2 RGL2 MAP4K4 SH2D3C	5.01e-07	200	275	10	e77eba6172cabf85b8028638ed35299f2f079cd8
ToppCell	Control_saline-Endothelial\|Control_saline / Treatment groups by lineage, cell group, cell type	SPTBN1 DACH1 PCDH12 PTK2 AFDN PLEC SIPA1L2 RGL2 MAP4K4 SH2D3C	5.01e-07	200	275	10	3372c488a39fe812fa94e4f0564594186fea3db5
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	BICDL2 KANK1 PTPN14 ATP8A1 DNAH5 ATP13A4 CACNB1 SHROOM3 LAMA5	6.68e-07	159	275	9	8680b054622f573a82b1625fb93c2d5db81d1034
ToppCell	368C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)\|368C / Donor, Lineage, Cell class and subclass (all cells)	NES DCHS2 DACH1 PCDH12 SH2D3C LAMA5 EDN2 KANK3 FUT1	9.58e-07	166	275	9	30a991fc3275b571d53bd0976df4789e5d40b01d
ToppCell	368C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-\|368C / Donor, Lineage, Cell class and subclass (all cells)	NES DCHS2 DACH1 PCDH12 SH2D3C LAMA5 EDN2 KANK3 FUT1	9.58e-07	166	275	9	76b4cd32698900797ec009f17e50ea7ae36b85f4
ToppCell	AT1-AT2_cells-Donor_03\|World / lung cells shred on cell class, cell subclass, sample id	SPTBN1 FYCO1 ATP13A4 PCLO LAMA5 TENT5B LINGO4 PEAK1 MDGA1	1.11e-06	169	275	9	815474855a70498a74e52f6583113c63b7267a0c
ToppCell	LPS-IL1RA+antiTNF-Unknown\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DCHS2 ARHGAP36 NPFFR2 MDN1 TMEM132A MYO18B MYH7B DENND2C	1.68e-06	132	275	8	a022c3c41654166cb106f27dc54fa88e8c40f898
ToppCell	LPS-IL1RA+antiTNF-Unknown-Endothelial\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DCHS2 ARHGAP36 NPFFR2 MDN1 TMEM132A MYO18B MYH7B DENND2C	1.68e-06	132	275	8	46c80eab16a70da9f363a9fbdf50bccab0b287d7
ToppCell	droplet-Tongue-nan-24m-Epithelial-keratinocyte\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BICDL2 MYCBP2 EVPL AFDN HBEGF RDH12 PIR TENT5B TIAM1	2.15e-06	183	275	9	9e6c96ada930e8559246a270dfc69fb3cbb3bdf3
ToppCell	COVID-19-lung-AT2\|lung / Disease (COVID-19 only), tissue and cell type	SHC3 PTPN3 KANK1 ATP8A1 DMBT1 ADGRF1 ATP13A4 SHROOM3 PCLO	3.05e-06	191	275	9	276455a64c2c3503d5048615762eb2ee37f0ac70
ToppCell	CF-Epithelial\|CF / Disease state, Lineage and Cell class	BICDL2 ZNF185 EVPL EPS8L1 PTPN3 AFDN ADGRF1 DENND2C LRATD2	3.33e-06	193	275	9	518901c2e36a79c6189cd0d9e6d36dbd4f56a79c
ToppCell	(6)_Endothelial-C_(Capillary_Aerocyte_)\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	NES SPTBN1 DACH1 PCDH12 SH2D3C LAMA5 EDN2 KANK3 FUT1	3.33e-06	193	275	9	f7f2dc6aff02d096a282835094d26d12b3b73e61
ToppCell	CF-Lymphoid\|CF / Disease state, Lineage and Cell class	ASXL1 MYCBP2 MDN1 ATP8A1 MICAL3 PPM1K IFNLR1 PWP1 LRBA	3.33e-06	193	275	9	11de07d13a7da223990b56fa89ba7fc1c3dd0122
ToppCell	CF-Epithelial-Epithelial_cell\|CF / Disease state, Lineage and Cell class	BICDL2 ZNF185 EVPL EPS8L1 PTPN3 AFDN ADGRF1 DENND2C LRATD2	3.33e-06	193	275	9	4e3dda27c71b7fdac90d081f0d8e9ca3a8ea7820
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Myeloid-Megakaryocyte\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CDKN2D NRXN2 NFE2 ANGPT4 KIF11 GALNT14 ANK1 EXOC8 FUT1	3.62e-06	195	275	9	1bcc0c8b1281396b1433ce5a2ec8681de47ce9ad
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Myeloid\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CDKN2D NRXN2 NFE2 ANGPT4 KIF11 GALNT14 ANK1 EXOC8 FUT1	3.62e-06	195	275	9	027075e9c62b5754a014a9d1393e1b0f5ae42e41
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TRPS1 PTPN3 KANK1 KIFC3 GALNT14 SHROOM3 PCLO PARD3B LRBA	3.77e-06	196	275	9	eea66711a16134f86e6c533a5a837ff2e0d7ca7f
ToppCell	Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CNPY4 BMP5 TTLL1 PCDHGB2 LAMA2 GAL3ST4 HTRA3 ADGRA2 CLDND2	4.10e-06	198	275	9	7d2fe57e0f9311ac1e6854402ebc154306eb1ba5
ToppCell	Bronchial-NucSeq-Epithelial-Epi_airway_basal-Suprabasal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CDH26 PTPN3 FAT2 FGF20 GALNT14 NWD1 EDN2 DENND2C RAPGEFL1	4.27e-06	199	275	9	f5c3561744e2a0e7716657cb521acb1d8f054b41
ToppCell	Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	NES SPTBN1 DACH1 PCDH12 AMER2 SH2D3C LAMA5 KANK3 FUT1	4.27e-06	199	275	9	14a7c4cf4bb3d43fd32ec9cc74f6625b225ffaa1
ToppCell	Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	NES SPTBN1 DACH1 PCDH12 AMER2 SH2D3C LAMA5 KANK3 FUT1	4.27e-06	199	275	9	7ed541309808f15d65a9c4b26be2050e077539e6
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	NES SPTBN1 DACH1 PCDH12 AFDN RGL2 SH2D3C MCTP1 HELZ2	4.45e-06	200	275	9	bcd1cc96197929d6011903803b6f4ccdcf52b4ce
ToppCell	LPS_IL1RA-Endothelial\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SPTBN1 DACH1 PCDH12 PTK2 AFDN SIPA1L2 RGL2 SH2D3C MCTP1	4.45e-06	200	275	9	5c092b2ecc081b5d04476c56333c338cd89ab984
ToppCell	Control_saline-Endothelial-Endothelial-Alv_Gen_Intermediate\|Control_saline / Treatment groups by lineage, cell group, cell type	SPTBN1 DACH1 PCDH12 AFDN SIPA1L2 RGL2 MAP4K4 SH2D3C TIAM1	4.45e-06	200	275	9	041a34080120c9f613373c20dcc366292f558040
ToppCell	Neuronal-Excitatory-eH(THEMIS)-CRABP1\|Neuronal / cells hierarchy compared to all cells using T-Statistic	ABCC3 TRPM4 DCHS2 ERCC4 TRPC4 DACH1 GALNT14 CSPG4 LRATD2	4.45e-06	200	275	9	a737c4f535723e389ba4b957ae1fdc5162d3d951
ToppCell	LPS_IL1RA-Endothelial-Endothelial\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SPTBN1 DACH1 PCDH12 PTK2 AFDN SIPA1L2 RGL2 SH2D3C MCTP1	4.45e-06	200	275	9	72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5
ToppCell	Neuronal-Excitatory-eH(THEMIS)-CRABP1-\|Neuronal / cells hierarchy compared to all cells using T-Statistic	ABCC3 TRPM4 DCHS2 ERCC4 TRPC4 DACH1 GALNT14 CSPG4 LRATD2	4.45e-06	200	275	9	473e85930f433e392956a7a10ea5d09fdc2a35b1
ToppCell	distal-Endothelial-Capillary_Intermediate_1-2\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	STARD13 NES SPTBN1 DACH1 PCDH12 SH2D3C LAMA5 EDN2 KANK3	4.45e-06	200	275	9	43bc48413b100a06f8edd9acd812296788fcbf5b
ToppCell	Neuronal-Excitatory-eH(THEMIS)-CRABP1--\|Neuronal / cells hierarchy compared to all cells using T-Statistic	ABCC3 TRPM4 DCHS2 ERCC4 TRPC4 DACH1 GALNT14 CSPG4 LRATD2	4.45e-06	200	275	9	73b7e395398fdc9aa5adb3ade675ae0168d7f46c
ToppCell	Neuronal-Excitatory-eH(THEMIS)-CRABP1---L5-6\|Neuronal / cells hierarchy compared to all cells using T-Statistic	ABCC3 TRPM4 DCHS2 ERCC4 TRPC4 DACH1 GALNT14 CSPG4 LRATD2	4.45e-06	200	275	9	c9113e7a9624499db3e66c01462159e8e8781cc4
ToppCell	distal-Endothelial-Capillary_Intermediate_1\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	STARD13 NES SPTBN1 DACH1 PCDH12 SH2D3C LAMA5 EDN2 KANK3	4.45e-06	200	275	9	4d6714d48738cdee7d535923f6dd2431e5304741
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|Adult / Lineage, Cell type, age group and donor	BICDL2 KLHL24 SHC3 ATP8A1 DNAH5 ATP13A4 SHROOM3 C20orf202	8.07e-06	163	275	8	e819a1d6d28290854aa0672b3a18fa9e293d8f23
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS-Exc_L5-6_THEMIS_IL7R\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ABCC3 TRPM4 DACH1 PTPN3 CD163L1 GALNT14 CSPG4 LRATD2	1.10e-05	170	275	8	6af7dee9b8298d4499e05a82cf9cdfe3bd81d384
ToppCell	3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.3\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	KLK7 ZNF185 EVPL EPS8L1 KIFC3 ADGRF1 TENT5B LRATD2	1.10e-05	170	275	8	13a225e32132e9717debb0d64d7c28ada974c3e6
ToppCell	5'-GW_trimst-2-LymphNode-Endothelial-blood_vessel_EC-venous_capillary\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SPTBN1 RAPGEF3 SIPA1L2 KLC3 TBCD HSPG2 MCTP1 KANK3	1.14e-05	171	275	8	b3e6e31dfe3623b960ccf692fdbd236fa4039923
ToppCell	PND01-03-samps-Mesenchymal-Matrix_fibroblast-FB-2\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	IL17C CCDC177 MICAL3 GALNT14 HTRA3 SLC1A3 ASXL3	1.27e-05	125	275	7	6cd741dd1c7ee6b16437cca7c15c99b5c95603fc
ToppCell	wk_20-22-Hematologic-Meg-ery-Cycling_definitive_erythroblast\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	CDKN2D CDKN3 NFE2 MYO18B SLC30A10 KIF23 ANK1 ABCB10	1.41e-05	176	275	8	98814f0a67411b2f7b25dc489b2aadb77f45a853
ToppCell	E16.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TNIK TTC16 NRXN2 NFE2 PARD3B MCTP1 INF2 DENND2C	1.47e-05	177	275	8	84591e28482ab62a5ef41e61043eb64912766356
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Endothelial\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NES SPTBN1 DACH1 RAPGEF3 AFDN HERC6 HBEGF KANK3	1.47e-05	177	275	8	ca5a30b3e7bcfdd8de01ceaf7449735b5cd503af
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Endothelial-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NES SPTBN1 DACH1 RAPGEF3 AFDN HERC6 HBEGF KANK3	1.47e-05	177	275	8	f471f7747d6e8db7546899019af9508f48a14f89
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Endothelial-endothelial_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NES SPTBN1 DACH1 RAPGEF3 AFDN HERC6 HBEGF KANK3	1.47e-05	177	275	8	cd0684b876c2a7d5fe7e2773e8e25bb61ecbc795
ToppCell	E16.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TNIK TTC16 NRXN2 NFE2 PARD3B MCTP1 INF2 DENND2C	1.47e-05	177	275	8	4bc100062891d07cacd10ffba38966cc6302c92f
ToppCell	E16.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TNIK TTC16 NRXN2 NFE2 PARD3B MCTP1 INF2 DENND2C	1.47e-05	177	275	8	9f3a2adb9cd4f0a059afc87b6e377a9702154bb1
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS-Exc_L5-6_THEMIS_THTPA\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ABCC3 TRPM4 KLK7 ERCC4 TRPC4 DACH1 CD163L1 GALNT14	1.53e-05	178	275	8	e4e11e4940c911c17806200c25096928153c684d
ToppCell	Children_(3_yrs)-Epithelial-basal_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CDH26 PTK2 PTPN14 NRXN1 DNAH5 ATP13A4 LAMA5 ASXL3	1.53e-05	178	275	8	fba2e38c05cbf031e0c6d47b1602575fea734a57
ToppCell	droplet-Heart-4Chambers-21m-Mesenchymal-nan\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SHC3 KANK1 NRXN2 TTLL1 PCDHGA4 GAL3ST4 ANGPTL6 CSPG4	1.59e-05	179	275	8	b44e2d53b82c3c141bfc6539054b19708200a0d9
ToppCell	E18.5-samps-Mesenchymal-Pericyte\|E18.5-samps / Age Group, Lineage, Cell class and subclass	NRXN1 LOXL3 ALG1 HBEGF MINK1 SH2D3C LAMA2 CSPG4	1.66e-05	180	275	8	0b1d370db64862fe1c7ea0ffaf06d03ec82e6e70
ToppCell	facs-Heart-RA-3m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRRC10B BMP5 NRXN1 ANGPT4 GALNT14 ATP13A4 HBEGF TENT5B	1.73e-05	181	275	8	395cf5aa2d89b05328ab516b8c89401020b6d830
ToppCell	facs-Heart-RA-3m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRRC10B BMP5 NRXN1 ANGPT4 GALNT14 ATP13A4 HBEGF TENT5B	1.73e-05	181	275	8	429df38438d5a7ff490c9ede34b69e2970c7ded2
ToppCell	Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	KANK1 RAPGEF3 ATP13A4 NWD1 PARD3B SLC1A3 ANGPTL4 MDGA1	1.73e-05	181	275	8	0c3f469bed108994ed696230e3c30343f7a301d3
ToppCell	5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FAM74A1 RAPGEF3 TBCD HSPG2 PIR MCTP1 KANK3 LRATD2	1.80e-05	182	275	8	d0e3663f7d39f22a3ebd7fde56ab3504773598f4
ToppCell	facs-Tongue-nan-24m-Epithelial-keratinocyte\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BICDL2 TNFSF13 EVPL KLC3 HBEGF RDH12 PIR TENT5B	1.80e-05	182	275	8	41f1749e2368397bca49143786da0423792f03bd
ToppCell	pdx-Tumor_cells-T6\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	STARD13 TRPS1 FGF20 SLC30A10 MYH7B SLC1A3 MCTP1 CTBP2	1.80e-05	182	275	8	7b24a4f712e1ae1525e8f1c8ec4e1fc43489cbee
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SFI1 NRXN1 USH2A DNAH5 ATP13A4 ANK1 PCLO ASXL3	1.94e-05	184	275	8	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SPTBN1 PTPN14 AFDN ATP13A4 SHROOM3 LAMA5 PARD3B PEAK1	1.94e-05	184	275	8	57c792e6e2fedba25d3350ffe649fd74750b579d
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SFI1 NRXN1 USH2A DNAH5 ATP13A4 ANK1 PCLO ASXL3	1.94e-05	184	275	8	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SFI1 NRXN1 USH2A DNAH5 ATP13A4 ANK1 PCLO ASXL3	1.94e-05	184	275	8	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SPTBN1 PTPN14 AFDN ATP13A4 SHROOM3 LAMA5 PARD3B PEAK1	1.94e-05	184	275	8	d7bd0f0c607bade67c99e9fb3578a570298bf926
ToppCell	droplet-Kidney-KIDNEY-1m-Epithelial-Pecam____kidney_capillary_endothelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SCARF2 SPEG TRPC4 PCDH12 LOXL3 PPM1N DNAI1 PCDHGB4	1.94e-05	184	275	8	1c857126c0ea0671f0d60b048efca288d348d653
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	BICDL2 SHC3 KANK1 ATP8A1 DNAH5 ATP13A4 SHROOM3 LRBA	2.10e-05	186	275	8	2ea5ff14861e5f91d0e6a5767c403a24045d715c
ToppCell	Thalamus-Endothelial\|Thalamus / BrainAtlas - Mouse McCarroll V32	NES CCDC102A HSPG2 LRRK1 ADGRA2 ANGPTL4 HELZ2 LRP5	2.10e-05	186	275	8	dcc6e4417c4123d5ca6b96fa8ca4874626aaebdb
ToppCell	10x3'2.3-week_17-19-Endothelial-stroma-proliferating_EC\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	DACH1 PCDH12 HMCN2 AFDN HSPG2 MXRA5 ADGRA2 KANK3	2.10e-05	186	275	8	a844d4f79e0ad5d6c60a4488ffd8f4f21b7eed04
ToppCell	5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TRPC4 DACH1 NPFFR2 BMP5 PCDH19 TMEM132A CACNB1 PCDHB7	2.10e-05	186	275	8	f07e0c0d9c80ac9d8d679950e7d0c812becb85a3
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1\|Adult / Lineage, Cell type, age group and donor	SPTBN1 PTPN14 AFDN ATP13A4 SHROOM3 LAMA5 PARD3B PEAK1	2.18e-05	187	275	8	77f78aec946bc6bd85c29aee9ca978ce49f853a3
ToppCell	COVID-19-Heart-EC_1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SPTBN1 DACH1 AFDN TBCD HSPG2 SH2D3C MCTP1 PEAK1	2.36e-05	189	275	8	fe49852ba15f948b384d6b4c258927c70b741357
ToppCell	primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TNFSF13 KANK1 RAPGEF3 ATP13A4 NWD1 PARD3B SLC1A3 ANGPTL4	2.45e-05	190	275	8	5c64b727669b23d2a23c8ad1d5d6caab7af37d56
ToppCell	LV-06._Ventricular_Cardiomyocyte_II\|World / Chamber and Cluster_Paper	TNIK KLHL24 KANK1 MYO18B MYH7B LAMA2 PPM1K SLC1A3	2.45e-05	190	275	8	de5ef606a002f85c2e0e3a36c1f259d0b85a76ff
ToppCell	droplet-Large_Intestine-COLON_-_"PROM_Tm"-30m-Epithelial-Lgr5+_undifferentiated_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RPS5 MYH7B PARD3B ZNF251 ASXL3 SUFU MTSS2	2.53e-05	139	275	7	c300f953ff9c5e820ff16bcd9942d279b37b79db
ToppCell	droplet-Large_Intestine-COLON_-_"PROM_Tm"-30m-Epithelial-intestinal_crypt_stem_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RPS5 MYH7B PARD3B ZNF251 ASXL3 SUFU MTSS2	2.53e-05	139	275	7	95b19d7459d9b54162cf01d278462245d34802d5
ToppCell	wk_15-18-Epithelial-Proximal_epithelial-MUC16+_ciliated\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	TTC16 LRRC10B CROCC2 GRIN3B DNAH5 NWD1 DNAI1 CCDC17	2.54e-05	191	275	8	e81cd65dbf0ef1c2ab7088f73ce605d456dd3a7a
ToppCell	facs-Skin\|facs / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT2 KANK1 AFDN PLEC KLC3 TIAM1 CSPG4 RAPGEFL1	2.54e-05	191	275	8	ae524103331fa53fa82888dbb567fc36abcee7e0
ToppCell	droplet-Tongue-nan-3m-Epithelial-suprabasal_interpapillary\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYCBP2 EVPL AFDN OSGIN1 ATP13A4 HBEGF PIR TIAM1	2.54e-05	191	275	8	abdd93b2313e635f75a750d051a6a01ddc4e2df9
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PTPN3 KANK1 ATP8A1 DNAH5 ATP13A4 CACNB1 SHROOM3 PCLO	2.64e-05	192	275	8	cc9911e182a289779a2612bc213daae5607689e7
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD\|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	ABCC3 MFHAS1 PTPN1 DNAH5 GALNT14 KIF23 HBEGF FOSL2	2.74e-05	193	275	8	ca7c0a4ceb05bced90f6cdc53d278e547fb241e9
ToppCell	human_hepatoblastoma\|World / Sample and Cell Type and Tumor Cluster (all cells)	ASXL1 TRIM24 PTK2 TNRC6A AFDN MAP4K4 PARD3B LRBA	2.74e-05	193	275	8	e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADAM11 FAT2 NRXN2 TMEM132A CACNA1G ANK1 PCLO SLC1A6	2.74e-05	193	275	8	5fb7808dd971c1cc64c2bd4f8f1de646fb2d77f4
ToppCell	NS-critical-d_0-4-Epithelial-Squamous\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	KLK7 ZNF185 EVPL EPS8L1 PTPN3 AFDN ADGRF1 DENND2C	2.84e-05	194	275	8	614d0c25b56957c70f397abb169fd2a860eb1c06
ToppCell	PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NES NRXN1 NRXN2 LOXL3 HBEGF LAMA2 CSPG4 ANGPTL4	2.95e-05	195	275	8	7a32a8535c29b819dacba901d0658280a2631c94
ToppCell	COVID-19-Heart-EC_1\|Heart / Disease (COVID-19 only), tissue and cell type	DACH1 RAPGEF3 AFDN TBCD SH2D3C LAMA5 MCTP1 KANK3	2.95e-05	195	275	8	50a193475db1bb1e05b8590225a553688c372c14
ToppCell	PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NES NRXN1 NRXN2 LOXL3 HBEGF LAMA2 CSPG4 ANGPTL4	2.95e-05	195	275	8	4a5d2f62aad5817d077177bf8b4ff0e46d3b8d97
ToppCell	facs-GAT-Fat-3m-Endothelial\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NES DACH1 PTPN14 RAPGEF3 AFDN SH2D3C LAMA5 KANK3	3.06e-05	196	275	8	b6cc1f466d45479764080d34b1daeb8243a5a9f3
ToppCell	facs-GAT-Fat-3m-Endothelial-endothelial_cell\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NES DACH1 PTPN14 RAPGEF3 AFDN SH2D3C LAMA5 KANK3	3.06e-05	196	275	8	ede6104cdfa4ee5287efcca9bbc36677cbf7a8d8
ToppCell	facs-GAT-Fat-3m-Endothelial-nan\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NES DACH1 PTPN14 RAPGEF3 AFDN SH2D3C LAMA5 KANK3	3.06e-05	196	275	8	039044ab28c53391c34d8226fb8cf78549e63ef4
ToppCell	NS-critical-LOC-Epithelial-Squamous\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	KLK7 ZNF185 EPS8L1 PTPN3 AFDN ADGRF1 TENT5B DENND2C	3.06e-05	196	275	8	453c809494ceffa2a28af283c4b5a4924fcf160f
ToppCell	COVID-19-lung-Capillary_Aerocytes\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SPTBN1 DACH1 PCDH12 STARD9 SIPA1L2 SH2D3C LAMA5 KANK3	3.06e-05	196	275	8	49cc0a2b9739abad61dff7292ea0b14d28ff35c4
Drug	0297417-0002B [362658-29-5]; Up 200; 10uM; MCF7; HT_HG-U133A	STARD13 KLHL24 ERCC4 EPS8L1 SFI1 PTPN14 ATP8A1 KIFC3 TMCO3 PML OSGIN1 CUL4B CCDC28A OGFR	5.21e-08	186	270	14	6900_UP
Drug	2-propylpentanoic acid; Down 200; 200uM; MCF7; HT_HG-U133A	ASXL1 KLHL24 SPTBN1 DACH1 EPS8L1 ACOX3 PLEC TBCD PML NPAT RNF31 OGFR MINK1 TRIM3	1.07e-07	197	270	14	5211_DN
Drug	BAS 012416453; Down 200; 38uM; MCF7; HT_HG-U133A	RABEP2 CDKN2D SPTBN1 EPS8L1 SFI1 SRCAP BMP5 TMCO3 OSGIN1 CASP9 RNF6 WDFY3 CROCC	7.56e-07	198	270	13	6880_DN
Drug	Ribostamycin sulfate salt [53797-35-6]; Up 200; 7.2uM; MCF7; HT_HG-U133A	ABCC3 SPTBN1 PAK6 BMP5 PTPN14 KCNS1 TTLL1 SGSM3 RNF31 OGFR FOSL2 MINK1 MCM9	8.00e-07	199	270	13	3444_UP
Drug	Beclomethasone dipropionate [5534-09-8]; Up 200; 7.6uM; PC3; HT_HG-U133A	TNIK SPTBN1 SFI1 PCDH12 PTK2 AFDN TTLL1 PML CACNB1 LAMA2 RNF6 ANGPTL4	3.20e-06	191	270	12	4580_UP
Drug	Hydralazine hydrochloride [304-20-1]; Up 200; 20.4uM; MCF7; HT_HG-U133A	KLK7 TRPC4 PCDH12 SRCAP KCNS1 PML OSGIN1 ANK1 SH3PXD2A KANK3 PCDH8 MTSS2	3.96e-06	195	270	12	4746_UP
Drug	Clemastine fumarate [14976-57-9]; Down 200; 8.6uM; HL60; HT_HG-U133A	RABEP2 EPS8L1 SGSM3 ALK PML CACNB1 MINK1 RGS14 SAFB2 LRP5 WDFY3 PEAK1	4.40e-06	197	270	12	2412_DN
Drug	Hexamethonium dibromide dihydrate [55-97-0]; Down 200; 10uM; PC3; HT_HG-U133A	CBLL1 ERCC4 AK1 AFDN PML OGFR MINK1 LRRK1 TRIM3 RNF6 SAFB2 FUT1	4.40e-06	197	270	12	6620_DN
Drug	Methiazole; Down 200; 15uM; MCF7; HT_HG-U133A	CDKN2D ABCC3 EVPL LRFN4 SGSM3 PLEC OSGIN1 MIIP HSPG2 MICAL1 OGFR MINK1	4.40e-06	197	270	12	4354_DN
Drug	Demecarium bromide [56-94-0]; Down 200; 5.6uM; MCF7; HT_HG-U133A	CDKN2D SPTBN1 EPS8L1 BMP5 SGSM3 HERC6 DMWD TBCD PIGL LONP2 MINK1 LRP5	4.40e-06	197	270	12	2773_DN
Drug	Methimazole [60-56-0]; Down 200; 35uM; HL60; HT_HG-U133A	PCDH12 SRCAP ATP8A1 AFDN DMWD OGFR FOSL2 SLC25A22 RGS14 BMP15 MTSS2 RAPGEFL1	4.64e-06	198	270	12	2570_DN
Drug	Sotalol hydrochloride [959-24-0]; Up 200; 13uM; HL60; HT_HG-U133A	LRFN4 ANGPT4 KCNS1 TTLL1 TBCD PML CACNB1 LAMA5 TRIM3 SH3PXD2A ANGPTL4 RAPGEFL1	4.64e-06	198	270	12	2918_UP
Drug	Carbachol [51-83-2]; Down 200; 21.8uM; PC3; HT_HG-U133A	RABEP2 SPEG ATP8A1 MICAL3 SGSM3 PML GALNT14 HSPG2 FOSL2 LRRK1 BMP15 RAPGEFL1	4.64e-06	198	270	12	6742_DN
Drug	Gabexate mesilate [56974-61-9]; Up 200; 9.6uM; MCF7; HT_HG-U133A	RABEP2 SPTBN1 PCDH12 SIK2 PML OSGIN1 MINK1 ADGRA2 EDN2 RGS14 MCTP1 WDFY3	4.64e-06	198	270	12	7357_UP
Drug	Ritodrine hydrochloride [23239-51-2]; Up 200; 12.4uM; MCF7; HT_HG-U133A	RABEP2 ABCC3 KLK7 DACH1 SFI1 PCDH12 NRXN1 ANGPT4 KCNS1 PML CROCC MTSS2	4.89e-06	199	270	12	2635_UP
Drug	Quinic acid [86-68-0]; Up 200; 19.6uM; HL60; HT_HG-U133A	DCHS2 MFHAS1 SPTBN1 SGSM3 TMCO3 PLEC PML ENTPD7 FOSL2 HUWE1 RGS14 CSPG4	4.89e-06	199	270	12	2978_UP
Drug	Karakoline [39089-30-0]; Down 200; 10.6uM; HL60; HT_HG-U133A	RABEP2 SPTBN1 EPS8L1 PTK2 TTLL1 TMCO3 ALK TBCD PML CACNB1 OGFR LRRK1	4.89e-06	199	270	12	2203_DN
Drug	fluphenazine dihydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A	RABEP2 KLHL24 ERCC4 SPTBN1 SFI1 SRCAP TTLL1 HERC6 MED12 TBCD PML	1.46e-05	186	270	11	6996_UP
Drug	Proglumide [6620-60-6]; Up 200; 12uM; MCF7; HT_HG-U133A	RABEP2 KLK7 SPEG SRCAP AK1 AFDN CACNA1G ALK OGFR HUWE1 RNF6	1.87e-05	191	270	11	3861_UP
Drug	Etofenamate [30544-47-9]; Up 200; 10.8uM; PC3; HT_HG-U133A	DCHS2 EPS8L1 PLEKHB1 ACOX3 SGSM3 KIFC3 DMBT1 DMWD ALK CACNB1 RNF6	2.06e-05	193	270	11	3989_UP
Drug	Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A	TRPM4 SRCAP BMP5 AK1 SGSM3 MICAL1 OGFR MINK1 TRIM3 WDFY3 RAPGEFL1	2.06e-05	193	270	11	5239_DN
Drug	Flumethasone [2135-17-3]; Up 200; 9.8uM; PC3; HT_HG-U133A	KCNS1 DMWD PML HSPG2 CACNB1 ANK1 FOSL2 MINK1 TRIM3 ANGPTL4 SAFB2	2.27e-05	195	270	11	4272_UP
Drug	Ethamsylate [2624-44-4]; Up 200; 15.2uM; HL60; HT_HG-U133A	KLK7 PLEKHB1 NRXN1 DMWD TBCD PML PIGL TIAM1 SH3PXD2A ANGPTL4 RAPGEFL1	2.38e-05	196	270	11	2915_UP
Drug	Sulfisoxazole [127-69-5]; Down 200; 15uM; MCF7; HT_HG-U133A	SPTBN1 PHF8 NPHP4 PTPN14 AK1 MIIP ENTPD7 OGFR FOSL2 CASP9 RNF6	2.38e-05	196	270	11	3218_DN
Drug	(-)-Eseroline fumarate salt [104015-29-4]; Down 200; 12uM; MCF7; HT_HG-U133A	ASXL1 KLHL24 EVPL SFI1 ACOX3 TTLL1 MED12 LONP2 INF2 SAFB2 LRP5	2.38e-05	196	270	11	7027_DN
Drug	Aminohippuric acid [61-78-9]; Up 200; 20.6uM; MCF7; HT_HG-U133A	SPTBN1 PRDM9 PTPN14 KCNS1 CACNA1G DMWD PML OSGIN1 OGFR PCLO TRIM3	2.49e-05	197	270	11	5394_UP
Drug	Myosmine [532-12-7]; Down 200; 27.4uM; PC3; HT_HG-U133A	ABCC3 SPTBN1 SRCAP DMBT1 PML OSGIN1 ENTPD7 OGFR ADGRA2 RNF6 SAFB2	2.61e-05	198	270	11	4293_DN
Drug	Guanabenz acetate [23256-50-0]; Down 200; 13.8uM; MCF7; HT_HG-U133A	TRPM4 PTPN14 SGSM3 HERC6 PML MICAL1 PCLO CASP9 TRIM3 BMP15 MTSS2	2.61e-05	198	270	11	5703_DN
Drug	Disulfiram [97-77-8]; Down 200; 13.4uM; PC3; HT_HG-U133A	TNIK SPTBN1 EVPL SFI1 SRCAP TMEM132A TBCD MIIP HSPG2 GAL3ST4 RGS14	2.61e-05	198	270	11	5729_DN
Drug	Paromomycin sulfate [1263-89-4]; Up 200; 5.6uM; HL60; HT_HG-U133A	TNIK ABCC3 TRPS1 PTPN3 PRDM9 ATP8A1 CACNA1G CACNB1 HUWE1 TRIM3 CSPG4	2.61e-05	198	270	11	3017_UP
Drug	Sulfamethoxazole [723-46-6]; Down 200; 15.8uM; PC3; HT_HG-U133A	TNIK NPHP4 TMEM132A DMWD GALNT14 HSPG2 RNF31 OGFR MINK1 TIAM1 MCM9	2.61e-05	198	270	11	7366_DN
Drug	Hymecromone [90-33-5]; Down 200; 22.8uM; MCF7; HT_HG-U133A	NES ACOX3 BMP5 PTPN14 AK1 HERC6 PML OGFR MINK1 WDFY3 BMP15	2.61e-05	198	270	11	5684_DN
Drug	SC-560; Down 200; 10uM; PC3; HT_HG-U133A	MFHAS1 SPTBN1 CNPY4 TBCD PML OSGIN1 MIIP OGFR MINK1 SH3PXD2A CSPG4	2.61e-05	198	270	11	6865_DN
Drug	Dosulepin hydrochloride [897-15-4]; Up 200; 12uM; MCF7; HT_HG-U133A	CNPY4 AK1 TTLL1 TRPM1 SGSM3 PML OSGIN1 CACNB1 PCLO TRIM3 RGS14	2.73e-05	199	270	11	5986_UP
Drug	Dioxybenzone [131-53-3]; Up 200; 16.4uM; HL60; HT_HG-U133A	SPTBN1 ZNF185 EPS8L1 NRXN1 KCND1 DMBT1 SLC30A10 ALK HSPG2 PCDHGB6 BMP15	2.73e-05	199	270	11	3101_UP
Drug	Methoxy-6-harmalan [3589-73-9]; Up 200; 18.6uM; PC3; HT_HG-U133A	ABCC3 CACNA1G SGSM3 PML ANK1 FOSL2 MINK1 GAL3ST4 TIAM1 CROCC MTSS2	2.73e-05	199	270	11	6355_UP
Drug	Cloxacillin sodium salt [642-78-4]; Down 200; 8.8uM; MCF7; HT_HG-U133A	RABEP2 ERCC4 SFI1 SRCAP PLEKHB1 AK1 PML HSPG2 CACNB1 HBEGF MINK1	2.73e-05	199	270	11	2289_DN
Drug	Chlorpyrifos	CDKN3 ABCC3 NES MYCBP2 TRPC4 SPTBN1 PTK2 CAVIN4 BMP5 FGF20 ETNK1 GRIN3B ALK KIF11 H1-10 LRFN1 LONP2 FOSL2 PCLO LAMA5 CASP9 HUWE1 SLC1A3 SLC1A6 GTF3C1 ANGPTL4	8.26e-05	960	270	26	ctd:D004390
Drug	genistein; Down 200; 10uM; HL60; HT_HG-U133A	ASXL1 NFE2 PLEC MED12 TBCD PML MIIP MINK1 EIF4G1 SAFB2	8.73e-05	188	270	10	1176_DN
Drug	5230742; Up 200; 17uM; MCF7; HT_HG-U133A_EA	KLHL24 NPHP4 LRFN4 PTPN14 MICAL3 OSGIN1 HSPG2 OGFR LAMA5 SAFB2	9.53e-05	190	270	10	970_UP
Drug	Tracazolate hydrochloride [41094-88-6]; Up 200; 11.8uM; MCF7; HT_HG-U133A	KLHL24 SRCAP AK1 SGSM3 TMCO3 PML OSGIN1 MICAL1 HBEGF MINK1	9.95e-05	191	270	10	7339_UP
Drug	SC 19220; Down 200; 10uM; PC3; HT_HG-U133A	CDKN2D SRCAP MICAL3 HSPG2 H1-10 MICAL1 RNF31 ZMAT3 MCTP1 FUT1	1.04e-04	192	270	10	7065_DN
Drug	Levodopa [59-92-7]; Down 200; 20.2uM; MCF7; HT_HG-U133A	RABEP2 CDKN2D SPTBN1 EPS8L1 SGSM3 PML PCLO RGS14 RNF6 SAFB2	1.08e-04	193	270	10	4394_DN
Drug	Acetohexamide [968-81-0]; Down 200; 12.4uM; MCF7; HT_HG-U133A	KLHL24 PLEKHB1 MICAL3 PLEC TBCD NPAT MICAL1 MINK1 TRIM3 ATP6V0A2	1.13e-04	194	270	10	1707_DN
Drug	ICI 182,780; Up 200; 1uM; PC3; HT_HG-U133A	ABCC3 PLEKHB1 ANGPT4 DMBT1 OGFR LRRK1 TRIM3 INF2 LRP5 RAPGEFL1	1.13e-04	194	270	10	1205_UP
Drug	Betonicine [515-25-3]; Up 200; 25.2uM; MCF7; HT_HG-U133A	AFDN PML MICAL1 CACNB1 PCDHGB6 FOSL2 PCLO MINK1 TRIM3 RGS14	1.18e-04	195	270	10	6063_UP
Drug	Nafronyl oxalate [3200-06-4]; Down 200; 8.4uM; MCF7; HT_HG-U133A	KLHL24 PLEKHB1 ACOX3 TTLL1 SGSM3 ENTPD7 CUL4B RNF6 LRP5 PKN1	1.18e-04	195	270	10	2622_DN
Drug	Clebopride maleate [84370-95-6]; Up 200; 8.2uM; HL60; HT_HG-U133A	CDKN2D DACH1 EPS8L1 SRCAP ACOX3 TMCO3 CACNB1 MINK1 ADGRA2 TRIM3	1.18e-04	195	270	10	1292_UP
Drug	Loracarbef [121961-22-6]; Up 200; 10.8uM; HL60; HT_HG-U133A	SFI1 AFDN PLEC PML ENTPD7 PIGL RNF31 FOSL2 LRRK1 PKN1	1.18e-04	195	270	10	2970_UP
Drug	Prazosin hydrochloride [19237-84-4]; Down 200; 9.6uM; PC3; HT_HG-U133A	ABCC3 EVPL EPS8L1 SFI1 AK1 MICAL1 RNF31 LAMA5 GAL3ST4 TRIM3	1.23e-04	196	270	10	6315_DN
Drug	Pirenzepine dihydrochloride [29868-97-1]; Down 200; 9.4uM; MCF7; HT_HG-U133A	RABEP2 NES KLHL24 EPS8L1 SGSM3 TRIM3 TIAM1 INF2 SAFB2 FUT1	1.23e-04	196	270	10	7226_DN
Drug	Bisoprolol fumarate; Down 200; 9uM; PC3; HT_HG-U133A	TRPM4 SFI1 PCDH12 AK1 HERC6 OGFR FOSL2 RNF6 MTSS2 RAPGEFL1	1.23e-04	196	270	10	6748_DN
Drug	Fluvoxamine maleate [61718-82-9]; Up 200; 9.2uM; HL60; HT_HG-U133A	SFI1 PFKL PHF8 SRCAP KCNS1 AFDN DMWD GALNT14 FOSL2 SH3PXD2A	1.23e-04	196	270	10	2913_UP
Drug	Betonicine [515-25-3]; Down 200; 25.2uM; HL60; HT_HG-U133A	TRPS1 EPS8L1 SFI1 LRFN4 KCNS1 SGSM3 TMCO3 ALK OGFR ZMAT3	1.23e-04	196	270	10	2207_DN
Drug	Asiaticoside [16830-15-2]; Up 200; 4.2uM; HL60; HT_HG-U133A	EPS8L1 SFI1 PHF8 LRFN4 AFDN SGSM3 PML ADGRA2 RGS14 LRP5	1.23e-04	196	270	10	2943_UP
Drug	Econazole nitrate [24169-02-6]; Down 200; 9uM; HL60; HT_HG-U133A	EPS8L1 SFI1 PCDH12 SRCAP LRFN4 NFE2 ALK CACNB1 RGS14 PKN1	1.23e-04	196	270	10	2396_DN
Drug	Alfadolone acetate [23930-37-2]; Down 200; 10.2uM; HL60; HT_HG-U133A	TNIK SPTBN1 SFI1 KANK1 SGSM3 PML MIIP CACNB1 PCLO LRRK1	1.28e-04	197	270	10	3127_DN
Drug	Naproxen [22204-53-1]; Down 200; 17.4uM; PC3; HT_HG-U133A	STARD13 KLHL24 GAK SRCAP LRP8 LRFN4 PLEC POLD1 INF2 EIF4G1	1.28e-04	197	270	10	1828_DN
Drug	estradiol; Up 200; 0.01uM; PC3; HT_HG-U133A	TRPM4 EPS8L1 ACOX3 TTLL1 SGSM3 ALK TBCD PML CACNB1 TRIM3	1.28e-04	197	270	10	5960_UP
Drug	Sulmazole [73384-60-8]; Up 200; 14uM; PC3; HT_HG-U133A	ABCC3 KLHL24 ADAM11 PRDM9 ATP8A1 SGSM3 MINK1 LAMA2 GAL3ST4 CSPG4	1.28e-04	197	270	10	4009_UP
Drug	Propidium iodide [25535-16-4]; Up 200; 6uM; PC3; HT_HG-U133A	RABEP2 NRXN2 KCNS1 AFDN TTLL1 FOSL2 APOF LAMA2 CROCC MTSS2	1.28e-04	197	270	10	5803_UP
Drug	Cefazolin sodium salt [27164-46-1]; Up 200; 8.4uM; MCF7; HT_HG-U133A	ABCC3 NES EPS8L1 BMP5 MICAL1 OGFR MINK1 LAMA2 RGS14 MCM9	1.28e-04	197	270	10	3426_UP
Drug	Isometheptene mucate; Down 200; 8.2uM; HL60; HT_HG-U133A	TNIK ZNF185 ACOX3 PML ENTPD7 PIGL FOSL2 MINK1 LRRK1 SAFB2	1.28e-04	197	270	10	3145_DN
Drug	Diethylcarbamazine citrate [1642-54-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A	DACH1 SRCAP TTLL1 MED12 MIIP FOSL2 MINK1 TRIM3 RGS14 SAFB2	1.28e-04	197	270	10	7425_DN
Drug	Deltaline [6836-11-9]; Down 200; 7.8uM; HL60; HT_HG-U133A	MFHAS1 EPS8L1 LRFN4 KCNS1 TMCO3 HERC6 TBCD OGFR RGS14 SAFB2	1.28e-04	197	270	10	2171_DN
Drug	Benzathine benzylpenicillin [5928-84-7]; Down 200; 4.2uM; PC3; HT_HG-U133A	ABCC3 TMEM132A TTLL1 SGSM3 ADGRF1 ALK FOSL2 TRIM3 MTSS2 RAPGEFL1	1.28e-04	197	270	10	4022_DN
Drug	Karakoline [39089-30-0]; Up 200; 10.6uM; MCF7; HT_HG-U133A	PHF8 ANGPT4 KCNS1 ANK1 OGFR HUWE1 ADGRA2 SLC1A6 EDN2 SAFB2	1.28e-04	197	270	10	6059_UP
Drug	Piribedil hydrochloride [78213-63-5]; Up 200; 12uM; MCF7; HT_HG-U133A	SFI1 AK1 AFDN DMWD PCLO RGS14 MCTP1 SH3PXD2A BMP15 MTSS2	1.28e-04	197	270	10	3512_UP
Drug	Dizocilpine maleate [77086-22-7]; Down 200; 11.8uM; PC3; HT_HG-U133A	TNIK MFHAS1 SRCAP TMEM132A SGSM3 PML RGS14 SAFB2 WDFY3 BMP15	1.28e-04	197	270	10	5746_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	TRPM4 ASXL1 ERCC4 DACH1 PLEKHB1 LRP8 MIIP GALNT14 OGFR WDFY3	1.34e-04	198	270	10	3332_DN
Drug	Methyldopa (L,-) [555-30-6]; Down 200; 19uM; MCF7; HT_HG-U133A	EPS8L1 SRCAP PLEKHB1 PLEC OSGIN1 NPAT FOSL2 RNF6 WDFY3 BMP15	1.34e-04	198	270	10	5272_DN
Drug	Fenofibrate [49562-28-9]; Down 200; 11uM; HL60; HT_HG-U133A	RABEP2 CNPY4 DACH1 EPS8L1 ACOX3 ALK CACNB1 OGFR RGS14 SAFB2	1.34e-04	198	270	10	2401_DN
Drug	Trimethadione [127-48-0]; Up 200; 28uM; HL60; HT_HG-U133A	CNPY4 TMEM132A KIFC3 PML CACNB1 LAMA2 LRRK1 INF2 CSPG4 PCDH8	1.34e-04	198	270	10	2486_UP
Drug	Bacitracin [1405-87-4]; Down 200; 2.8uM; HL60; HT_HG-U133A	TNIK PTPN1 SGSM3 TBCD PML ENTPD7 FOSL2 PCLO MINK1 LAMA2	1.34e-04	198	270	10	3109_DN
Drug	CP-944629 [668990-94-1]; Up 200; 10uM; PC3; HT_HG-U133A	KLHL24 MFHAS1 SRCAP LRFN4 PML CACNB1 OGFR MINK1 TRIM3 INF2	1.34e-04	198	270	10	7549_UP
Drug	Quinic acid [86-68-0]; Up 200; 19.6uM; MCF7; HT_HG-U133A	ABCC3 SPTBN1 SRCAP KCNS1 AFDN PML CACNB1 PCDHGB6 TRIM3 RGS14	1.34e-04	198	270	10	6019_UP
Drug	5248896; Down 200; 11uM; MCF7; HT_HG-U133A_EA	RABEP2 ABCC3 PTPN1 SIK2 TMCO3 PLEC DMWD NPAT PIGL LONP2	1.34e-04	198	270	10	955_DN
Drug	Phensuximide [86-34-0]; Up 200; 21.2uM; MCF7; HT_HG-U133A	CDKN2D DACH1 SFI1 SGSM3 ALK PML MINK1 ADGRA2 RGS14 CSPG4	1.34e-04	198	270	10	3521_UP
Drug	Thiethylperazine malate [52239-63-1]; Up 200; 6uM; HL60; HT_HG-U133A	STARD13 ZNF185 DMBT1 OGFR PCLO MINK1 LAMA5 TRIM3 RNF6 BMP15	1.34e-04	198	270	10	6154_UP
Drug	Zoxazolamine [61-80-3]; Up 200; 23.8uM; MCF7; HT_HG-U133A	SRCAP BMP5 KCNS1 PML OSGIN1 MICAL1 OGFR HBEGF PCLO TRIM3	1.34e-04	198	270	10	5390_UP
Drug	Hydroquinine hydrobromide hydrate [304695-81-6]; Down 200; 9.4uM; MCF7; HT_HG-U133A	SFI1 SRCAP PLEKHB1 PTPN14 TMEM132A SIK2 PLEC HSPG2 PIGL INF2	1.34e-04	198	270	10	2767_DN
Drug	H-89, Dihydrochloride; Down 200; 0.5uM; MCF7; HT_HG-U133A	RABEP2 SPTBN1 EPS8L1 SFI1 SRCAP SGSM3 MIIP OGFR MINK1 CROCC	1.34e-04	198	270	10	6878_DN
Drug	ICI 182,780; Up 200; 0.01uM; PC3; HT_HG-U133A	KLHL24 CNPY4 DACH1 EPS8L1 SFI1 TTLL1 OSGIN1 CACNB1 ANK1 HUWE1	1.34e-04	198	270	10	4462_UP
Drug	Heptaminol hydrochloride [543-15-7]; Down 200; 22uM; PC3; HT_HG-U133A	SPEG MICAL3 KIFC3 PML OGFR GAL3ST4 SLC1A3 TRIM3 INF2 SAFB2	1.34e-04	198	270	10	1825_DN
Drug	Proxyphylline [603-00-9]; Down 200; 16.8uM; HL60; HT_HG-U133A	TNIK SFI1 SRCAP PLEC MIIP ENTPD7 CACNB1 OGFR FOSL2 MINK1	1.40e-04	199	270	10	3115_DN
Drug	Flucytosine [2022-85-7]; Up 200; 31uM; HL60; HT_HG-U133A	SPTBN1 ZNF185 AFDN PLEC CACNB1 OGFR GAL3ST4 LRRK1 TRIM3 LRP5	1.40e-04	199	270	10	3073_UP
Drug	Acetazolamide [59-66-5]; Up 200; 18uM; MCF7; HT_HG-U133A	KLHL24 SRCAP PML MIIP CACNB1 PIGL RNF31 RGS14 WDFY3 BMP15	1.40e-04	199	270	10	7461_UP
Drug	Nortriptyline hydrochloride [894-71-3]; Down 200; 13.4uM; HL60; HT_HG-U133A	RABEP2 ACOX3 MICAL3 ALK TBCD PML CACNB1 RGS14 EIF4G1 SAFB2	1.40e-04	199	270	10	2391_DN
Drug	Chenodiol [474-25-9]; Down 200; 10.2uM; HL60; HT_HG-U133A	RABEP2 CNPY4 EPS8L1 SFI1 PCDH12 PLEC ALK CACNB1 MINK1 RGS14	1.40e-04	199	270	10	2402_DN
Drug	Homochlorcyclizine dihydrochloride [1982-36-1]; Down 200; 10.4uM; HL60; HT_HG-U133A	CNPY4 EPS8L1 PCDH12 LRFN4 MICAL3 ALK CACNB1 PIGL OGFR PEAK1	1.40e-04	199	270	10	2386_DN
Drug	Mefloquine hydrochloride [51773-92-3]; Down 200; 9.6uM; HL60; HG-U133A	RABEP2 SFI1 NFE2 KCNS1 SGSM3 DMWD MED12 MINK1 SLC25A22 MCTP1	1.40e-04	199	270	10	1364_DN
Drug	Arecoline hydrobromide [300-08-3]; Up 200; 17uM; MCF7; HT_HG-U133A	CDKN2D ABCC3 SPTBN1 BMP5 KCNS1 PML OSGIN1 CACNB1 WDFY3 BMP15	1.40e-04	199	270	10	5423_UP
Drug	Tetracaone hydrochloride [136-47-0]; Down 200; 13.2uM; MCF7; HT_HG-U133A	DACH1 EVPL NPHP4 PML PIGL OGFR MINK1 CASP9 SAFB2 FUT1	1.40e-04	199	270	10	7473_DN
Drug	Norcyclobenzaprine [303-50-4]; Down 200; 15.4uM; MCF7; HT_HG-U133A	GAK SPTBN1 SFI1 NPHP4 PLEKHB1 PLEC OGFR MINK1 TIAM1 WDFY3	1.40e-04	199	270	10	2830_DN
Drug	Sulfamerazine [127-79-7]; Up 200; 15.2uM; MCF7; HT_HG-U133A	ABCC3 ADAM11 PCDH12 AK1 OSGIN1 HBEGF PCLO RGS14 BMP15 MTSS2	1.45e-04	200	270	10	4740_UP
Drug	Adiphenine hydrochloride [50-42-0]; Down 200; 11.4uM; HL60; HT_HG-U133A	KLHL24 SRCAP ACOX3 LRFN4 TBCD ENTPD7 FOSL2 RGS14 SAFB2 LRP5	1.45e-04	200	270	10	1872_DN
Drug	Pentetic acid [67-43-6]; Down 200; 10.2uM; MCF7; HT_HG-U133A	ABCC3 SPTBN1 DACH1 EPS8L1 SRCAP TTLL1 ALK MED12 TBCD TRIM3	1.45e-04	200	270	10	5264_DN
Disease	mental development measurement	PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA4 PCDHGB4	2.53e-06	25	264	5	EFO_0008230
Disease	childhood trauma measurement, alcohol consumption measurement	PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA4 PCDHGB4	3.46e-06	71	264	7	EFO_0007878, EFO_0007979
Disease	brain aneurysm	STARD13 AMER2 CD163L1 ANGPT4 MINK1 PARD3B ZNF746 RP1L1	8.41e-06	113	264	8	EFO_0003870
Disease	Sarcosine measurement	PCDHGB3 PCDHGB2 PCDHGA4 PCDHGB4	4.85e-05	23	264	4	EFO_0021668
Disease	glycochenodeoxycholate glucuronide (1) measurement	ABCC3 CACNA1G ENTPD7	1.90e-04	13	264	3	EFO_0800474
Disease	urolithiasis	MINDY4 SLC30A10 SHROOM3 RGS14 PKN1	2.54e-04	63	264	5	MONDO_0024647
Disease	creatinine measurement	SPEG DACH1 PTPN3 PTPN14 NRXN2 SGSM3 PLEC CERS2 SHROOM3 MYH7B OGFR LAMA2 LAMA5 CASP9 SLC1A3 RGS14 MED4 CSPG4 DOCK7 PCDHGB4 SUFU	2.68e-04	995	264	21	EFO_0004518
Disease	Situs ambiguus	PKD1L1 DNAH5 SHROOM3	2.98e-04	15	264	3	C0266642
Disease	FEV/FEC ratio	STARD13 ASXL1 DCHS2 SCARF2 SPEG TRPS1 MCM7 PTK2 DDX5 KANK1 CROCC2 MICAL3 DMBT1 DNAH5 SLC30A10 PML HSPG2 SLC1A3 SH3PXD2A CSPG4 SUFU CCDC17 ATP6V0A2 RAPGEFL1	3.05e-04	1228	264	24	EFO_0004713
Disease	electrocardiography	MYCBP2 MFHAS1 SPEG SPTBN1 ADAM11 PTK2 PTPN3 HMCN2 CACNA1G TMCO3 PLEC MYO18B SH3PXD2A SUFU	3.33e-04	530	264	14	EFO_0004327
Disease	congenital stationary night blindness (is_implicated_in)	TRPM1 GUCY2D	4.73e-04	4	264	2	DOID:0050534 (is_implicated_in)
Disease	Kartagener syndrome (is_implicated_in)	DNAH5 DNAI1	4.73e-04	4	264	2	DOID:0050144 (is_implicated_in)
Disease	hippocampal CA4 volume	TNIK PKD1L1 TMEM132A ZNF398	4.89e-04	41	264	4	EFO_0009396
Disease	age-related hearing impairment	SPTBN1 ZNF185 SFI1 PTK2 PTPN14 M1AP SLC25A10 CTBP2 MDGA1 CCDC17	7.29e-04	324	264	10	EFO_0005782
Disease	kallikrein-7 measurement	KLK7 CD163L1	7.83e-04	5	264	2	EFO_0008195
Disease	muscular dystrophy (implicated_via_orthology)	CAVIN4 LAMA2 TRIM3	8.36e-04	21	264	3	DOID:9884 (implicated_via_orthology)
Disease	stearoyl sphingomyelin (d18:1/18:0) measurement	KANK3 ANGPTL4	1.17e-03	6	264	2	EFO_0800611
Disease	brain disease (implicated_via_orthology)	MYCBP2 TIAM1	1.17e-03	6	264	2	DOID:936 (implicated_via_orthology)
Disease	episodic ataxia type 6 (implicated_via_orthology)	SLC1A3 SLC1A6	1.17e-03	6	264	2	DOID:0050994 (implicated_via_orthology)
Disease	Metastatic melanoma	PTK2 GUCY2D PKN1 PEAK1	1.39e-03	54	264	4	C0278883
Disease	brain measurement, neuroimaging measurement	TNIK DCHS2 SPTBN1 TRPS1 PTK2 PGM1 LRP8 TNRC6A PLEC MCTP1 SH3PXD2A CTBP2 SUFU	1.48e-03	550	264	13	EFO_0004346, EFO_0004464
Disease	epidermolysis bullosa simplex (is_implicated_in)	KLHL24 PLEC	1.63e-03	7	264	2	DOID:4644 (is_implicated_in)
Disease	Alzheimer's disease 1 (implicated_via_orthology)	KLC3 KLC4	1.63e-03	7	264	2	DOID:0080348 (implicated_via_orthology)
Disease	mean fractional anisotropy measurement	MFHAS1 PLEC HBEGF SH3PXD2A WDFY3	1.66e-03	95	264	5	EFO_0008399
Disease	serum urea measurement	DACH1 SHROOM3 RGS14 CSPG4 PCDHGB4 LRATD2 FUT1	1.95e-03	195	264	7	EFO_0009795
Disease	syndromic X-linked intellectual disability (implicated_via_orthology)	PHF8 HUWE1	2.15e-03	8	264	2	DOID:0060309 (implicated_via_orthology)
Disease	mean platelet volume	SPTBN1 SRCAP NFE2 TNRC6A KCNS1 PLEC TBCD MICAL1 PCDHGB7 PCDHGB6 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA4 ZMAT3 DENND2C MCM9 DOCK7 PCDHGB4	2.22e-03	1020	264	19	EFO_0004584
Disease	Huntington disease, disease progression measurement	PRDM9 TRPM1 MINDY4	2.40e-03	30	264	3	EFO_0008336, MONDO_0007739
Disease	autism spectrum disorder (implicated_via_orthology)	TRPC4 NRXN1 NRXN2 RIMS4 WDFY3 LRBA	2.53e-03	152	264	6	DOID:0060041 (implicated_via_orthology)
Disease	cortical thickness	TNIK CDKN3 KLHL24 MYCBP2 SPTBN1 TRPS1 PGM1 LRP8 ANGPT4 TNRC6A MICAL3 PLEC HSPG2 SHROOM3 LAMA2 ADGRA2 SH3PXD2A DOCK7 PCDHGB4 CTBP2	2.59e-03	1113	264	20	EFO_0004840
Disease	Schizophrenia	TNIK TNFSF13 IL17C LRP8 PTPN1 NRXN1 NRXN2 TRPM1 ALK MED12 PML LAMA2 SLC1A3 SLC1A6 SH3PXD2A MDGA1 PCDH8	2.68e-03	883	264	17	C0036341
Disease	Parkinson's disease (implicated_via_orthology)	GAK PAK6 ATP13A4 HTRA3 LRRK1 EIF4G1	2.97e-03	157	264	6	DOID:14330 (implicated_via_orthology)
Disease	Ciliopathies	NPHP4 USH2A DNAH5 RDH12 GUCY2D	3.15e-03	110	264	5	C4277690
Disease	nephrolithiasis	MINDY4 DMBT1 RGS14	3.17e-03	33	264	3	EFO_0004253
Disease	triglyceride measurement, intermediate density lipoprotein measurement	TRPS1 SHROOM3 KANK3 ANGPTL4 DOCK7	3.27e-03	111	264	5	EFO_0004530, EFO_0008595
Disease	Cryptogenic Tonic-Clonic Epilepsy	NES HBEGF	3.42e-03	10	264	2	C0751117
Disease	Epilepsy, Tonic-Clonic, Symptomatic	NES HBEGF	3.42e-03	10	264	2	C0751119
Disease	Epilepsy, Tonic-Clonic, Familial	NES HBEGF	3.42e-03	10	264	2	C0751118
Disease	Tonic-Clonic Epilepsy	NES HBEGF	3.42e-03	10	264	2	C0014549
Disease	rheumatoid arthritis, systemic lupus erythematosus	COG6 ICAM3	3.42e-03	10	264	2	EFO_0000685, MONDO_0007915
Disease	oleoyl-linoleoyl-glycerol (18:1/18:2) [2] measurement	ANGPTL4 DOCK7	3.42e-03	10	264	2	EFO_0800333
Disease	epilepsy (implicated_via_orthology)	TNIK ETNK1 MAP4K4 MINK1 SLC1A3 SLC1A6	3.58e-03	163	264	6	DOID:1826 (implicated_via_orthology)
Disease	R-6-hydroxywarfarin measurement	TRPS1 RBM15 SHROOM3 NWD1 LRBA	3.67e-03	114	264	5	EFO_0803327
Disease	creatinine measurement, chronic kidney disease	DACH1 CERS2 SHROOM3	3.75e-03	35	264	3	EFO_0003884, EFO_0004518
Disease	creatinine measurement, glomerular filtration rate	DACH1 CERS2 SHROOM3 CASP9 PCDHGB4	4.10e-03	117	264	5	EFO_0004518, EFO_0005208
Disease	Congenital disorder of glycosylation	PGM1 COG6 ALG1	4.74e-03	38	264	3	cv:C0282577
Disease	cortical surface area measurement	TNIK RABEP2 CDKN3 DCHS2 MYCBP2 MFHAS1 SPTBN1 PLEKHB1 PGM1 LRP8 PTPN1 TNRC6A MAP4K4 PIGL SHROOM3 LAMA2 GAL3ST4 PARD3B ADGRA2 RP1L1 CTBP2 SUFU	4.95e-03	1345	264	22	EFO_0010736
Disease	dentate gyrus volume measurement	TNIK PKD1L1 ZNF398	5.10e-03	39	264	3	EFO_0010083
Disease	serum alanine aminotransferase measurement	MFHAS1 PKD1L1 TRPS1 NRXN2 SLC30A10 OSGIN1 ENTPD7 PPP1R21 SHROOM3 MYH7B PCLO LAMA5 ZNF251 RP1L1 MCM9 PCDHGB4	5.41e-03	869	264	16	EFO_0004735
Disease	cholesterol in very small VLDL measurement	TRPS1 DOCK7 FUT1	5.48e-03	40	264	3	EFO_0022231
Disease	Infantile Severe Myoclonic Epilepsy	PCDH19 TNRC6A	5.83e-03	13	264	2	C0751122
Disease	Leber congenital amaurosis (implicated_via_orthology)	RDH12 GUCY2D	5.83e-03	13	264	2	DOID:14791 (implicated_via_orthology)
Disease	attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement	ERCC4 TRPC4 DACH1 PLEKHB1 SHC3 PTK2 NRXN1 NRXN2 TNRC6A SIPA1L2 USH2A MINK1 LAMA2 MCTP1 CTBP1	6.01e-03	801	264	15	EFO_0003888, EFO_0007052, MONDO_0002491
Disease	S-7-hydroxywarfarin to S-warfarin ratio measurement	STARD13 LEMD3 TRPS1 TIAM1	6.08e-03	81	264	4	EFO_0803334
Disease	liver fat measurement	PLEC RBM15 HAVCR2	6.71e-03	43	264	3	EFO_0010821
Disease	subiculum volume	TNIK CDKN3 SPTBN1	6.71e-03	43	264	3	EFO_0009399
Disease	Kartagener syndrome (implicated_via_orthology)	DNAH5 DNAI1	6.76e-03	14	264	2	DOID:0050144 (implicated_via_orthology)
Disease	early cardiac repolarization measurement	MYCBP2 LRP5	6.76e-03	14	264	2	EFO_0004885
Disease	hemorheological measurement	NRXN1 GTSCR1	7.75e-03	15	264	2	EFO_0803374
Disease	neuroimaging measurement	TNIK DCHS2 SPTBN1 TRPS1 PAK6 PLEKHB1 PTK2 PGM1 LRP8 PTPN1 AMER2 TNRC6A PLEC SHROOM3 HBEGF LAMA2 SH3PXD2A CTBP2	8.01e-03	1069	264	18	EFO_0004346
Disease	peripheral arterial disease, traffic air pollution measurement	TNIK TRPS1 COG6 MCTP1 LRBA PCDH8	8.22e-03	194	264	6	EFO_0004265, EFO_0007908
Disease	alcohol use disorder (implicated_via_orthology)	EPS8L1 ANGPT4 ANGPTL6 ANGPTL4 CTBP1 CTBP2	8.42e-03	195	264	6	DOID:1574 (implicated_via_orthology)
Disease	Leber congenital amaurosis	RDH12 GUCY2D	8.81e-03	16	264	2	cv:C0339527
Disease	pro-hydroxy-pro measurement	ALK MCTP1	8.81e-03	16	264	2	EFO_0021132
Disease	myopia (is_implicated_in)	LOXL3 LAMA2	8.81e-03	16	264	2	DOID:11830 (is_implicated_in)

Protein segments in the cluster

Peptide	Gene	Start	Entry
RLAAGDQLLSVDGRS	AFDN	1051	P55196
QELAVTTGRIRGDFR	MAMDC4	181	Q6UXC1
GDVETAQRLSQRRRG	FAM74A1	11	Q5RGS3
TNDLLRGIEAALGTR	ADCK1	441	Q86TW2
VRRVSNRGLAGTTIR	AMER2	646	Q8N7J2
RELQAEAGRTRGALE	CCDC17	191	Q96LX7
ALELQRSQTRRGRAG	CCDC17	276	Q96LX7
RLQGLDGQNTRDTRE	CCDC61	161	Q9Y6R9
EAQLGRSREEALAGR	CCDC61	196	Q9Y6R9
ELSRTGRSREVLELG	CNPY4	51	Q8N129
TERDAGSGLVTRLRE	ALG1	261	Q9BT22
LGQGLREHAERTRSQ	ANGPTL4	51	Q9BY76
QIREVASGAARIRGE	CTBP1	161	Q13363
EQIREVASGAARIRG	CTBP2	166	P56545
RGGRRLLTTDDVAFS	CSPG4	1031	Q6UVK1
GRAGTLRALSRQDTF	CACNB1	486	Q02641
DLVELQRGLASGDRS	ACOX3	376	O15254
SGDRSARQAELGREI	ACOX3	386	O15254
RGRVLIGSDQFQRSL	ADGRF1	461	Q5T601
SLEAGEELRGSTRLR	ADGRA2	966	Q96PE1
LLAREQQSTGRVGRS	APOF	151	Q13790
FGSGLTREEQEIRRL	ATP13A4	166	Q4VNC1
RLGAVGRARSREEEN	ARHGEF5	386	Q12774
RGDRELVVLRSENGS	ANK1	1001	P16157
SRLVRESSGGEVRKQ	ADAM11	51	O75078
RLGAVGRARSREEEN	ARHGEF35	386	A5YM69
LLGRSVTENLSDGLR	ABCB10	281	Q9NRK6
TGATTGELLQRLRDI	EDN2	136	P20800
LSERFGRGSRTVDLE	ARFIP2	111	P53365
QSISIGRGTRKRDED	DNAI1	16	Q9UI46
DSSDLELRLVGGTNR	CD163L1	256	Q9NR16
RLSGAAARGDVQEVR	CDKN2D	11	P55273
VAREEGLRRLFSGAT	SLC25A10	151	Q9UBX3
LRQSGERLRQSGERF	CAVIN4	241	Q5BKX8
GGRTDAERTIQDGRL	DACH1	736	Q9UI36
ELLSRQSGLSGRQVE	CERS2	101	Q96G23
GRFATLTLQERRDRG	DMWD	521	Q09019
QVVGDSRLGLRDQSS	ARMCX4	1481	Q5H9R4
VDRQVGTDGLLRLSS	ASXL1	291	Q8IXJ9
INEGSLDGTRETLSR	ATP8A1	711	Q9Y2Q0
GRNTGARTLADIKAR	ASXL3	1046	Q9C0F0
LRSGAQEARRLGLIT	NWD1	141	Q149M9
RNQGLRLIFTDGSRI	PGM1	486	P36871
SAGRRVTQLRGDDLR	RBM15	26	Q96T37
EAGRERRALSVQQRG	NPFFR2	26	Q9Y5X5
RSGGNQVRRRVLLSS	PPM1K	11	Q8N3J5
VTALREGRRGSIQVD	HSPG2	4296	P98160
ESGELSRLRAELAGA	RABEP2	36	Q9H5N1
RRGRRGAVSVDSLAE	ARHGAP36	181	Q6ZRI8
LTRTQAVNRRSALGD	RNF130	331	Q86XS8
RSGSLITAGRIDREE	PCDHGA11	81	Q9Y5H2
RALGGRINNIRTSEL	PTPN3	6	P26045
ALGQLRIESTLDGSR	KCTD19	301	Q17RG1
LSGGQRQRVSLARAV	ABCC3	751	O15438
LRTGEVRTARALGDR	PCDHGB6	621	Q9Y5F9
SLGLRTGEVRTARAL	PCDHGB4	616	Q9UN71
DSVRQRLLVAVRDGG	PCDHGB7	636	Q9Y5F8
SEEGLLSTGRRLDRE	PCDH12	81	Q9NPG4
NESRVRTETRRIGGA	LEMD3	726	Q9Y2U8
AGSQRARTRTGIAEI	NPAT	106	Q14207
VAELLGESDGRRTSQ	KLC4	506	Q9NSK0
ETLRIERIARTQGGR	MDGA1	91	Q8NFP4
VRVSDRDSGLNGRVQ	PCDH19	371	Q8TAB3
RSGTLVTAGRIDREE	PCDHGA4	111	Q9Y5G9
IGKETARELASRGAR	RDH12	51	Q96NR8
ATEERRAVLRLGAGS	RELCH	31	Q9P260
DRILEVNGRDVTGRT	PARD3B	431	Q8TEW8
DFGVSAQLDRTVGRR	MAP4K4	171	O95819
AQLDRTVGRRNTFIG	MAP4K4	176	O95819
QDTEVRSRVVGGSLR	PTPN1	366	P18031
TSRRRAQSLGLLGDE	PAK6	106	Q9NQU5
SRGDEVLVVNVSGRR	KCND1	36	Q9NSA2
TGAETRIRLSGGRSQ	LOXL3	411	P58215
QEERRELSSSSGLGL	MICAL3	1416	Q7RTP6
GGNRSSSREQELALR	MDN1	286	Q9NU22
QVRDSTLGAGRRRLN	NOB1	386	Q9ULX3
DVRLQERTSGGLLSE	NOP53	66	Q9NZM5
TREAGVRSLDRKLGA	LONP2	556	Q86WA8
GAGRAEQGSTLRRRI	MCTP1	111	Q6DN14
RVSEGRARGLQEAAR	LZTS2	486	Q9BRK4
RSQGASLRLAVEDGL	M1AP	106	Q8TC57
EATQELAAGRRRTVG	ENTPD7	241	Q9NQZ7
AESTQRTEDRGRTLG	IFNLR1	501	Q8IU57
SARLGLQAGLTEDRL	MFHAS1	686	Q9Y4C4
EAGRSLSTALRARGL	GUCY2D	196	Q02846
TRGRQRSGTEAASVL	LRRK1	526	Q38SD2
TQRLLKRGETSGRVD	AK1	126	P00568
GEQLQTERERGRTAA	FYCO1	271	Q9BQS8
LVVETIRRLGERNGS	H1-10	51	Q92522
SAGSDRQGRDLRVLA	HMCN2	3761	Q8NDA2
LTRILQDSLGGRTRT	KIF11	316	P52732
LGNSSRTRVRGDGTL	LRFN1	341	Q9P244
RTRVRGDGTLDVTIT	LRFN1	346	Q9P244
TRIGLRNALREEISG	KIAA1109	3241	Q2LD37
QGRLSVGSNRDREIS	KIAA1109	4436	Q2LD37
GTDRIEVTRLNGTSR	LRP5	436	O75197
SLLRRTRQADGISAE	BMP15	261	O95972
ELRRSGSRDVTGALL	CCDC28A	36	Q8IWP9
LLQLVEDRGSGRSRG	DDX5	471	P17844
RGRLQTESGELSRLL	MYH7B	1326	A7E2Y1
LEAAQRESRGLGTEL	MYH7B	1516	A7E2Y1
SIGGISSRARLLQDD	PCLO	4226	Q9Y6V0
VSGNEQGRFRLDART	FAT2	3256	Q9NYQ8
NTRGATRDIGSALTR	MTSS2	66	Q765P7
LRTGEVRTARALGDR	PCDHGB2	621	Q9Y5G2
SSLLRVREGDGQLTV	PCDH8	71	O95206
LATVAARDRDLGRNG	PCDH8	516	O95206
RRTGEILLTGDLSQE	PCDH8	666	O95206
RSRGSRLNIIIIAEG	PFKL	251	P17858
RGNETNSRETFLGRI	PEAK1	166	Q9H792
LSGSLDEEVGRRRQL	EVPL	1391	Q92817
VLSREQSEGVGARVR	PIR	11	O00625
GTIRRRRVEGSLAVS	PPM1N	216	Q8N819
RRVEGSLAVSRALGD	PPM1N	221	Q8N819
TQLTRDLLRSRGIAG	SLC25A22	171	Q9H936
QDEESLGGRRRTDAL	INTS2	236	Q9H0H0
ATVAREGNSAQRRLG	RASGRP4	151	Q8TDF6
GADSRELQRRRTAGS	HERC6	6	Q8IVU3
RSRDLRGLAEAQGAV	NRXN2	666	Q9P2S2
ETSLGQARERLGRAV	NES	201	P48681
QLEQLSRARRSGGEL	KANK1	331	Q14678
GSDTLGDRRAQRIKA	KLK7	81	P49862
RRRDSGIGEETATGL	LRBA	1601	P50851
RGGSRALAAVREATQ	LMLN2	86	A0A1B0GTW7
SGDQQLELSGRRLRR	LRRC10B	21	A6NIK2
TDASQGRRGRVVNDL	LRATD2	156	Q96KN1
RRQGGRNISVETASL	MED12	1261	Q93074
QEERRLSELALGTGA	MICAL1	1051	Q8TDZ2
ERKRGLQDGLRSSSN	GNL1	21	P36915
RTGRNGTISVRALDG	LAMA2	2236	P24043
NRGRLEVHLSTGART	LAMA2	2591	P24043
DARTGRETAALNSVR	IL17C	136	Q9P0M4
RRSDEALRVNVGGVR	KCNS1	46	Q96KK3
RGSEKLVSRLRGEAA	KLC3	441	Q6P597
EGLGTRLRAQSRQRS	LAMA5	3406	O15230
AGGNSTRERLLSALE	MED4	21	Q9NPJ6
QRDGRSGTISVNTLR	NRXN1	581	Q9ULB1
EAARQRLLVTVRDGG	PCDHGB3	636	Q9Y5G1
ANRRILLSSTESREG	PPP1R21	546	Q6ZMI0
SRLRRQLESGGFEAR	EXOC8	11	Q8IYI6
SGLTAEDRQLTARAR	GAL3ST4	346	Q96RP7
LQLSRGDSGTRDTVL	HUWE1	3606	Q7Z6Z7
LARLSGRGVARISDA	INF2	81	Q27J81
GLLERTASRLGSRAS	MVB12A	181	Q96EY5
RELVSGGRSVRFSEA	MCM7	666	P33993
LGRRGTSVLAQQSVR	NPHP4	931	O75161
VTLGGERREARENLT	ICAM3	296	P32942
ARAEDRDSGRNGLIR	DCHS2	1001	Q6V1P9
RSRIRGADIAQGTTL	GALNT14	181	Q96FL9
TNSSGSLGGLDVRRR	CBLL1	11	Q75N03
IRGGRGRRESTEIFQ	GTSCR1	46	Q86UQ5
RECGRGFSRQSVLLT	PRDM9	611	Q9NQV7
VGELRARGTRIVSDQ	PCDHB7	56	Q9Y5E2
LDEFGTARRSTVVRG	COG6	266	Q9Y2V7
SNFSVIGAREERGVR	GAK	1151	O14976
QRERESVSGGRTRKA	CEFIP	801	Q711Q0
GLSTGLRLAESRAEA	CROCC	341	Q5TZA2
AGELRTGLQEVERSR	CROCC	1261	Q5TZA2
ARRSVDGRLSGVQAE	CROCC	1566	Q5TZA2
TAQREGRELGLRDSD	HTRA3	276	P83110
STRRARVGVAAVGNR	KLHL17	376	Q6TDP4
LRNDILVSGGRINSR	KLHL24	361	Q6TFL4
IVGRRSLERTTSGDD	DOCK7	441	Q96N67
GLAQLLRGEDSRRSS	C20orf202	106	A1L168
IRTDSLDVQGLGSRE	CACNA1G	2136	O43497
TASREDRALTVRGEG	CROCC2	36	H7BZ55
EEGQRRVEGALSSAR	CROCC2	1421	H7BZ55
DRLRTTTNVLGDSLG	SLC1A3	476	P43003
AGSGSRRDQARQLII	CASP9	46	P55211
ELARLRGARGVADQT	CCDC102A	156	Q96A19
DGRVILSRQGSLSES	DDX11L8	581	A8MPP1
IGTTVGRRRRDEQLS	FOSL2	106	P15408
GEVRALRKESRGLSA	ANGPTL6	91	Q8NI99
SAALTNIERGLRGVR	ANGPT4	231	Q9Y264
QTIREELGRNSGSAL	DENND2C	286	Q68D51
NSLFLRESGQRLGRV	SLC1A6	6	P48664
VRASLAEETRGARKG	BMP5	101	P22003
AGAELRTRLESLQGE	BICDL2	191	A1A5D9
VQRSSLSRERGEKAG	EIF4G1	1141	Q04637
GVFDLDSTRRILQRG	AMDHD1	236	Q96NU7
LGRISSRNLGRDDRV	ASNSD1	526	Q9NWL6
SGFRVDRLSGEIRLS	CDH26	216	Q8IXH8
TERLATSERGGRARA	KANK3	251	Q6NY19
REAGTQRSVEVREAG	KHDC3L	141	Q587J8
QRGTRLASSGDDLRV	DCAF8L1	206	A6NGE4
EREGLRSSLEASLGR	CCDC177	526	Q9NQR7
LRERAGLSSAAVQTR	ETNK1	16	Q9HBU6
VTGESLERLRRGLAA	HBEGF	21	Q99075
GRGERRAAALRATQE	EPS8L1	161	Q8TE68
LRRRDLGQVSVGSFE	HELZ2	846	Q9BYK8
QAIDSLRDLRGSGAI	CDKN3	166	Q16667
SESSLALRLVNGGDR	DMBT1	1116	Q9UGM3
GGTLQERAARLFSVR	SDE2	416	Q6IQ49
RELNLAISRDSRGGR	POLD1	166	P28340
GTREDCVLSLGRTRT	PKD1L1	2436	Q8TDX9
TGIEDGELRRTLQSL	CUL4B	771	Q13620
ASRTRRELLGLSDEG	GARNL3	906	Q5VVW2
ADGGLLNSVRRLLSD	DNAH5	156	Q8TE73
VDGGRRRTLFSRNLS	LRP8	526	Q14114
DGTLEIRSVQLRDRG	LINGO4	466	Q6UY18
KRRGLRNSRATAGDI	OSGIN1	161	Q9UJX0
RTRAEGNRLREAGNI	KIF23	346	Q02241
ESLELEGTEAGRRRS	NFE2	156	Q16621
DFGVSAQLDRTVGRR	MINK1	171	Q8N4C8
AQLDRTVGRRNTFIG	MINK1	176	Q8N4C8
RLEDRGTGTVGRAQN	OGFR	181	Q9NZT2
GDVETAQRLSQRRRG	FAM74A4	11	Q5TZK3
GIQRTDATGTRVRGE	MCM9	331	Q9NXL9
SRRDTGDAGLRARLA	GRIN3B	206	O60391
LLGERRSAAERSARG	FGF20	36	Q9NP95
QSVLGQLRLGRTGDR	FUT1	196	P19526
TRIGRAGTVRRQAVD	RPS5	126	P46782
RNELSGTLSGLTRVR	TARS3	521	A2RTX5
GTLSGLTRVRRFQQD	TARS3	526	A2RTX5
AQGLRTERTGRVRAA	SFI1	596	A8K8P3
LLRNGIERFRGTSLS	USH2A	3536	O75445
GGGSADLIRNLRSRV	RGL2	201	O15211
VRDRRDSGVGASLTR	STARD13	566	Q9Y3M8
VLGSRARRAGVISRE	TMCO3	626	Q6UWJ1
DAGDSRRLKGAIQRS	RIMS4	31	Q9H426
RVLDSRVASLEGGRV	TMEM132A	586	Q24JP5
REQGGRLGAESRTLL	PIGL	31	Q9Y2B2
QAQEVSRLRSELGGT	KIFC3	116	Q9BVG8
LGRLDAVLQRIRTGS	PML	316	P29590
DVRLSRGSIDREDGS	PTK2	836	Q05397
SRLANDLRDSGATIR	HAVCR2	186	Q8TDQ0
RGDLRDVARSGVASL	MIIP	81	Q5JXC2
NGLSVARVSGREENR	PTPN14	871	Q15678
GAGTLTNLSQVVRRR	SGSM3	386	Q96HU1
LRGLSSAARERAGAR	SHC3	81	Q92529
SNSGGFRRTISRLER	RNF6	436	Q9Y252
TGGEGDRRIALSRAN	SIPA1L2	416	Q9P2F8
REGRRASDTSLTQGI	SIK2	581	Q9H0K1
LGATSFRRRDLELGA	SHROOM3	936	Q8TF72
LIRTGSVGRNRAEAS	SAE1	81	Q9UBE0
RRVNSGDTEVGSSLL	MYCBP2	3501	O75592
AENLRRATTDLGRSL	PKN1	56	Q16512
DLVTELQGRSRRREG	SIRT7	56	Q9NRC8
DELGGSQRGRSSLQR	STARD9	3956	Q9P2P6
RRRTSADVEIRGQGT	SRCAP	2721	Q6ZRS2
SGAERRDRAAAQVGT	TENT5B	6	Q96A09
TGRRLVSDGNINSDR	SPTBN1	1231	Q01082
SEVGREGRLSAAIRA	ALK	196	Q9UM73
LRIRCDEGESLRGQT	CLDND2	81	Q8NHS1
EEGVASGRTRRRTQS	PAK6-AS1	76	Q8N910
GRLLTAAEQRGSREA	CNOT11	11	Q9UKZ1
RSTVDAVQGGRDVLR	RNF31	106	Q96EP0
GRRERLVLGSARNSS	PWP1	471	Q13610
GSDGLSRRDAREVAI	SLC30A10	441	Q6XR72
DARGVATSLGLNERL	RAPGEF3	616	O95398
ESQSLLRRRRGSGVF	TRPS1	881	Q9UHF7
SERGGEAARLNLLDT	TRIM24	41	O15164
DFGVSAQLDRTVGRR	TNIK	171	Q9UKE5
AQLDRTVGRRNTFIG	TNIK	176	Q9UKE5
RRGIRLLDSGSVENV	ZSWIM5	181	Q9P217
SAGGRSTVREINRDA	WDFY3	1736	Q8IZQ1
VAARTGETGVRRRTQ	TIAM1	666	Q13009
AGGRERAVVALASRT	MINDY4	506	Q4G0A6
RRGELRRGSSAESAL	SPEG	2006	Q15772
RGLRNLSAFSERTLG	RP1L1	1611	Q8IWN7
SRDGLLTVNLREGGR	PLEKHB1	91	Q9UF11
ALRRNESLTATDGLR	SH3PXD2A	996	Q5TCZ1
ESLTATDGLRGVRRN	SH3PXD2A	1001	Q5TCZ1
AAELRGKTRSLGRAE	SCARF2	776	Q96GP6
SRRLLHLEGRTGTAE	ZNF398	61	Q8TD17
ERRSLRAAQTGQVDG	SOGA1	41	O94964
SGKDTEQIRETLRRG	SUFU	301	Q9UMX1
RELGGTANAALRRES	RGS14	246	O43566
GVAETGTRRLSELRV	SAFB2	21	Q14151
GLEAGSRRQARSRES	SLX9	156	Q9NSI2
DTVRRALRGANVIAG	PLEC	3151	Q15149
GSERIGLEVDRRASR	YTHDC1	151	Q96MU7
RGRAGSDEGNLSLRV	MYO18B	2291	Q8IUG5
GIDRSDLIQARSRAS	TRPM1	1236	Q7Z4N2
TEATVGRERSLGERT	ZNF251	166	Q9BRH9
GRERSLGERTQECSA	ZNF251	171	Q9BRH9
SESSELGQRRARKEG	ZMAT3	186	Q9HA38
DTTNLAGRRTLQGRA	PHF8	21	Q9UPP1
RNGDFLIRDSLTSLG	SH2D3C	236	Q8N5H7
GESAETRALLGRLRE	TBCD	31	Q9BTW9
SKVDATQGRSRGLLR	TTC16	786	Q8NEE8
REGRDETNLDLVRGT	ERCC4	646	Q92889
ESQAARLLSLEGRTG	ZNF746	26	Q6NUN9
GSTLARARLSGDVLN	ZNF831	1081	Q5JPB2
NRVLERLAGGATRDS	RAPGEFL1	156	Q9UHV5
ISERRTIKQESGRAG	GTF3C1	826	Q12789
GSQELSSRGEEIVRL	ZNF185	271	O15231
GTGESQSRDRRKIDQ	TNRC6A	686	Q8NDV7
QSLRREVSRLQGTGG	TNFSF13	56	O75888
DLLRRGLVRAAQSTG	TRPM4	136	Q8TD43
ERNIQLESRGLASRG	TRPC4	881	Q9UBN4
GADRELRSRQGQSLG	TTLL1	391	O95922
DGRLVRTGSAELRAE	TRIM3	351	O75382
RNGTSLRVLEGQSLR	SIGLEC16	346	A6NMB1
QDLRRALEEGSRESG	ATP6V0A2	336	Q9Y487
RIGARAFGDLESLRS	LRFN4	86	Q6PJG9
GRVSLLDNGTLTVRE	MXRA5	2686	Q9NR99
DAFTQELRRGLRGRS	NCBP2AS2	71	Q69YL0